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ABSTRACT
Pathogenic micro-organisms have the potential to invade the body and damage the host.
Thus the ability to combat pathogens is vital to all organisms. The innate immune system is the
first defense mechanism to be activated after pathogen invasion or tissue damage. The principal
innate immune effector cells, macrophages, reside in tissues, and during normal homeostasis, they
scavenge unwanted and recyclable material, including apoptotic cells. When pathogens invade a
tissue or cells are damaged, macrophages detect the presence of pathogen-derived or endogenous
molecules in inappropriate compartments through their pattern recognition receptors (PRRs). The
activation of macrophages after the stimulation of their PRRs triggers their defense reactions; they
start to secrete proteins evoking inflammation, recruiting other immune cells to the site, and
repairing tissue damage. The secretion of one of the most important inflammatory cytokines,
interleukin(IL)-1β, is regulated by an intracellular protein complex called the inflammasome. The
activation of certain PRRs triggers the assembly of the inflammasome and subsequently the
secretion of IL-1β. However, there is still no detailed characterization of the secretory responses
from activated macrophages or of the molecular signaling pathways leading to activation of the
inflammasome.
Monosodium urate (MSU) and extracellular adenosine triphosphate (ATP) are endogenous
molecules which signal danger to the innate immune system. The purine metabolite, uric acid,
crystallizes into MSU and when its concentration is elevated during cell rupture or metabolic
dysfunction, it activates innate immune cells, inducing an inflammatory reaction. ATP is the carrier
of chemical energy inside the cells, but when it is released into the extracellular space from
damaged cells, it is rapidly detected by the innate immune cells. In this thesis the secretory
responses activated by MSU and ATP from human macrophages were investigated. Fungal-derived
trichothecene mycotoxins represent an exogenous danger signal to the innate immune system,
evoking an inflammatory response from macrophages. In this thesis, the intracellular signaling
pathways activated by trichothecene mycotoxins in human macrophages were studied.
Furthermore, inflammatory responses induced by bacteria-derived signals from macrophages of
subjects with a history of reactive arthritis (ReA), an inflammatory joint disease which is following
a bacterial infection in another compartment of the body, were explored.
The results show that activation of macrophages with MSU and ATP induces a robust
unconventional protein secretion from the cells. MSU activates the secretion of cytokines and
chemokines, interferon-induced proteins and danger signal proteins from macrophages exposed to
bacteria-derived lipopolysaccharide (LPS). The results also demonstrate that this MSU-induced
unconventional protein secretion is dependent on the activity of cathepsins. Furthermore,
contributions from Src, Pyk2 and PI3 kinases are required for MSU-induced protein secretion.  The
results also show that macrophages exposed to extracellular ATP display a rapid secretion of
extracellular vesicles, and this secretion is dependent on the activity of calpains. The presence of
ATP triggers the secretion of danger signal proteins from macrophages. Furthermore, it was
demonstrated that the activity of calpains is required for ATP-induced secretion of IL-1β and
activation of NLRP3 inflammasome in LPS-exposed macrophages.
The results presented here also reveal that trichothecene mycotoxins activate the NLRP3
inflammasome in human macrophages. Trichothecenes activate the NLRP3 inflammasome
through the P2X7 receptor leading to the activation of cathepsins, the formation of reactive oxygen
species, potassium efflux, and activity of Src family kinases. Finally, the current results
demonstrate that inflammasome activation in macrophages from subjects with a history of ReA is
normal compared to cells from healthy subjects. In contrast, the secretion of two inflammatory
cytokines,  tumor  necrosis  factor  (TNF)  and  IL-23,  is  lower  from  macrophages  of  former  ReA
subjects compared to the corresponding release of these cytokines from cells of healthy controls.
The experiments presented in this thesis have provided novel information about innate
immune responses which may be useful in the treatment of inflammatory disorders.
11. INTRODUCTION
1.1 INNATE IMMUNE SYSTEM
We all encounter numerous species of microorganisms every day. Microorganisms are
pathogenic if they cause a disease or damage tissue after gaining entry into the host. Thus,
protection from the pathogenic organisms has been crucial to the survival of life forms since the
dawn of evolution. During the course of evolution, different defense mechanisms have evolved to
protect organisms from pathogenic microorganisms. In vertebrates, the immune system consists of
two arms - the innate immune system and the adaptive immune system. The innate immune
system is the first defense system to be activated upon pathogen invasion. The innate immune
system has the ability to recognize broad classes of pathogens (bacteria, viruses, fungi) through
their specialized pattern recognition receptors (PRRs) (Medzhitov and Janeway, 2000).
Endogenous molecules released from damaged cells also activate innate immune responses.
Several defense responses are mounted by innate immune cells including inflammatory processes
aiming at elimination of the pathogen and the recruitment of other immune cells to the infected
site. These innate immune responses are activated instantaneously or at the latest within hours
upon pathogen invasion or tissue damage; they are nonspecific since they are not targeted towards
specific pathogens but instead towards broad classes of pathogens. The innate immune system also
regulates the activation of the adaptive immune system (Iwasaki and Medzhitov, 2010) which takes
days, as it is slower than the innate immune system, but it is more specific, targeted towards the
specific pathogen causing the infection. Adaptive immunity is based on activation by specific
antigens derived from the pathogen, and involves the proliferation of antigen-specific T- and B-
lymphocytes. This leads to killing of the cells infected by the pathogen, and the production of
specific antibodies targeted against the infecting pathogen.
The innate immune system can be broadly divided into two parts, i.e. constantly present
components and others that are rapidly inducible upon pathogen invasion. The first compartments
of the host to encounter a pathogen will be the epithelial lining of the skin, and the mucosa of
respiratory, gastrointestinal and urogenital tract which represent a mechanical barrier preventing
the pathogens from entering the body. In addition, there are chemical barriers like gastric acid in
stomach, digestive enzymes in the upper gut, and enzymes in tears and saliva which attempt to
prevent pathogen invasion. Epithelial cells and phagocytic innate immune cells also secrete
antimicrobial peptides like defensins that are able to disrupt the integrity of bacterial cell walls
(Selsted and Ouellette, 2005). Antimicrobial peptides are constantly produced, but it has been
reported that their secretion might be also induced in response to pathogen invasion (Selsted and
Ouellette, 2005).
If a pathogen is able to penetrate through the epithelium, it will encounter the next innate
immune defense system called the complement system. The complement system consists of a
group  of  proteins  circulating  in  blood  and  other  body  fluids.  If  there  is  no  infection,  the
complement proteins remain in an inactive form. The complement system is activated when it
detects the presence of a pathogen directly after the binding of a complement protein to the
bacterial surface, or by binding to bacteria already bound by antibodies. There are three different
pathways of complement activation. The classical pathway is activated when complement protein
C1 binds to the pathogen surface or to antibodies bound onto the bacterial surface. The alternative
pathway is initiated when complement protein C3 is spontaneously hydrolyzed and binds to the
bacterial surface. The lectin pathway is activated when mannose-binding lectins and ficolins bind
to carbohydrates present on the bacterial wall (Ricklin et al., 2010). In all cases, the binding
initiates a protein cleavage cascade where proteins cleave consecutive proteins activating each in
2turn. All of the pathways converge in the cleavage of protein C3 resulting in binding of fragment
C3b on the pathogen surface, leading to the rapid amplification of complement activation and
opsonization of the pathogen. The complement cleavage cascade also leads to the formation of a
protein complex called the membrane attack complex on the pathogen surface disrupting its
membrane integrity  (Dunkelberger and Song, 2010).
Finalizing the actions of the complement system requires the involvement of professional
innate immune cells that engulf bacteria and eliminate them. A major part of the innate immune
defenses in higher vertebrates consists of cell-mediated innate immunity. This inducible part of
innate immunity relies on the detection of pathogens or tissue damage by effector cells of innate
immunity leading to phagocytosis of the pathogen, trapping the microorganism inside intracellular
vesicles prior to their elimination, and presentation of their antigens to the cells of the adaptive
immune system. The detection of pathogen and tissue damage causes innate immune cells to
rapidly produce and secrete proteins which are intended to create an inflammatory response,
recruitment of other cells to the site of damage and subsequently the repair of the damaged tissue
(Iwasaki and Medzhitov, 2010). Ultimately the activation of the cells of the innate immune system
leads to clearance of the pathogen from the host and the restoration of homeostasis, either through
the actions of the innate immune system alone, or by subsequent activation of the adaptive
immune system, which then finally eliminates the pathogen.
1.1.1 Cells of the innate immune system
The most important cells in the innate immune system are macrophages, dendritic cells
(DCs) and neutrophils able to phagocytose, i.e. engulf, pathogens into their intracellular vesicles.
Macrophages and dendritic cells also possess the ability to process and present antigens from
phagocytosed bacteria to the cells of the adaptive immunity system through their major
histocompatibility complex (MHC) class II proteins (in humans, MHC proteins are called HLA
proteins), hence they are also called antigen-presenting cells (APCs). Macrophages and dendritic
cells are located mainly in tissues, where they act as sentries, constantly guarding against the
presence of pathogens and integrity of cells. Neutrophils are mainly circulating in blood, where
they  can  be  rapidly  recruited  to  the  site  of  infection  or  wound.  During  the  early  stage  of  an
infection, the most numerous immune cells at the site are neutrophils ingesting pathogens to their
intracellular vesicles thus eliminating them. Macrophages, dendritic cells and neutrophils are all
leukocytes,  derived  from  common  myeloid  progenitor  in  the  bone  marrow  (Figure 1). Other
leukocytes involved in innate immune responses are monocytes that circulate in blood and are
recruited to the site of infection, and maturate into macrophages in tissues, eosinophils and
basophils, and mast cells (Iwasaki and Medzhitov, 2015). The most important feature of innate
immune cells is their intrinsic ability to recognize the presence of pathogens and endogenous
molecules derived from damaged tissues, and to respond rapidly to the insult.
3Figure 1. Cells of the innate
immune system. The main effector
cells are myeloid cells macrophages
and dendritic cells residing in
tissues, and circulating neutrophils,
which are rapidly recruited to tissues
upon innate immune system
activation. There are also some cells
of  lymphoid  lineage,  which  behave
like innate immune cells rather than
adaptive immune cells. These are
natural killer (NK) cells, innate
lymphoid cells (ILCs), specialized T
cells called γ/δ-T cells, invariant
natural killer T (iNKT) cells, and B-1
cells (Bendelac et al., 2001; Walker et
al., 2013). CLP, common lymphoid
progenitor; CMP, common myeloid
progenitor; GMP, granulocyte-
macrophage progenitor.
Macrophages can be found in virtually every tissue. There are many tissue-specific
subpopulations of macrophages with distinctive characteristics (Gordon et al., 2014). During early
embryonic development, embryonic progenitor cells are recruited to tissues to form the initial
population of tissue-specific macrophages. There is evidence that during normal homeostasis,
tissue populations of macrophages are self-renewing, and only when there are conditions of stress,
are monocytes from blood recruited into the tissues to give rise to new macrophages (Gentek et al.,
2014). Macrophages have vital functions during normal homeostasis; they are scavenger cells, and
they ingest foreign and endogenous substances by phagocytosis (Davies et al., 2013). During
phagocytosis, the cell engulfs extracellular substances into the intracellular phagosome, which
fuses with other intracellular vacuoles such as lysosomes. The resulting phagolysosome has a
highly acidic environment as well as an abundance of toxic reactive oxygen species (ROS) and nitric
oxide (NO), and antimicrobial proteins and peptides which lead to the degradation of the ingested
substance (Flannagan et al., 2012). The cell debris and cells undergoing programmed cell death (a
process called apoptosis) generated by tissue remodeling or renewal of cells are taken up and
removed by macrophages. Macrophages also participate in developmental processes and in the
regulation of metabolism (Mosser and Edwards, 2008; Davies et al., 2013). Importantly, this
maintenance work being undertaken by macrophages in the absence of signals from pathogens or
tissue damage does not activate pro-inflammatory responses in these cells (Mosser and Edwards,
2008).
In contrast, when pathogens have invaded a tissue, then the defense responses in
macrophages become activated. The ability of macrophages to ingest and eliminate invading
pathogens was the function that led to their discovery in 1882 by Élie Metchnikoff. The importance
of this finding is highlighted by the fact that he shared a Nobel Prize in Physiology or Medicine in
1908 for describing the process of phagocytosis (Tauber, 2003). Macrophages detect also
endogenous danger signals derived from damaged host tissues in situations of uncontrolled cell
death. This makes them the main detector of danger in the host (Mosser and Edwards, 2008).
Tissue macrophages initiate the defense responses, but during the course of infection, recruited
monocyte-derived macrophages become the major macrophage population in infected tissue
4(Davies et al., 2013). Macrophages receive signals secreted by themselves and by other innate
immune cells, and also signals secreted by adaptive immune cells later in infection. The recruited
monocytes differentiate into distinctive macrophage lineages depending on which cytokines are
present (Figure 2.). Historically, two distinct populations of macrophages have been defined: the
classically activated pro-inflammatory M1 and the alternatively activated anti-inflammatory M2
macrophages. Lately, alternatively activated macrophages have been referred to as wound-healing
macrophages, and a third type of macrophage, regulatory macrophages, has been identified
(Mosser and Edwards, 2008). In the early innate immune response, tumor necrosis factor (TNF)
and interferon(IFN)-β secreted by activated macrophages and dendritic cells, or IFN-γ secreted by
activated NK cells promote the development of classically activated macrophages. They produce
ROS and NO to enable intracellular destruction of engulfed pathogens, and they secrete large
amounts of pro-inflammatory cytokines such as interleukin(IL)-1β, IL-6, IL-12, IL-23, and TNF
(Murray and Wynn, 2011).
Figure  2. Macrophages in tissues. Tissue-specific subtypes of resident macrophages are mainly self-
renewing but upon infection monocytes are recruited to tissues to generate a population of monocyte-derived
macrophages taking part in defense reactions. Activated macrophages acquire classically activated, wound-
healing and regulatory phenotypes depending on environmental factors. CNS, central nervous system; Mφ,
macrophage.
During the course of an infection, other innate immune cells like granulocytes (neutrophils,
basophils, eosinophils) as well as adaptive immune system cells like antigen-specific T
lymphocytes, like T helper cell types (Th)1, Th2, Th17, and  T regulatory (Treg) cells will enter the
site (see 1.4). Th1 cells secrete TNF and IFN-γ promoting classically activated macrophage
differentiation. In contrast, Th2 cells secrete cytokines IL-4 and IL-13 that promote wound-healing
macrophages. Furthermore, basophils and mast cells can produce IL-4 and IL-13 thus promoting
wound-healing macrophage production (Murray and Wynn, 2011). These macrophages secrete only
low amounts of pro-inflammatory cytokines, and produce very little ROS and NO. Instead they
secrete components of the extracellular matrix. In wound-healing macrophages, the activity of the
enzyme arginase is upregulated and this promotes the synthesis of amino acid ornithine from
amino acid argininin. Ornithine can be used in production of polyamines and collagen,
components of extracellular matrix (Gordon, 2003; Mosser and Edwards, 2008).
Regulatory macrophages also possess anti-inflammatory properties. Their differentiation is
promoted by anti-inflammatory cytokine IL-10 secreted by variety of cells including Treg cells. In
5addition, glucocorticoid hormones secreted from the cortex of the adrenal gland during stress
might promote their differentiation. Regulatory macrophages also secrete IL-10 themselves, but
they do not secrete components of extracellular matrix and in that respect they differ from the
wound-healing macrophages. Regulatory macrophages appear to have a role in the late stages of
adaptive immunity, possibly to reduce the inflammation and dampen the immune reactions
(Mosser and Edwards, 2008). During inflammation, the population of macrophages might change
their phenotype according to chemokines and other signals originating from the environment.
They might also express the characteristics of two populations at the same time. Macrophages are
hence very versatile cells, capable of responding to changes in their environment. However, to date,
the roles and phenotypic changes of resident macrophages during an infection and subsequently on
its resolution, have been much more poorly characterized than those of the recruited monocyte-
derived macrophages (Gordon et al., 2014).
1.2 RECOGNITION OF PATHOGENS BY INNATE IMMUNE CELLS
Innate immune cells are able to recognize the presence of broad classes of pathogens by their
germ line -encoded receptors on their cell surface and inside cytoplasm that are called pattern
recognition receptors (PRRs). PRRs have an intrinsic ability to detect molecular patterns common
to pathogens or their products. These molecules are collectively called pathogen-associated
molecular patterns (PAMPs). The principle of pathogen recognition by common molecular
structures found on bacteria, viruses, or fungi was presented in 1989 by Charles Janeway (Janeway,
1989). The basis of the concept was that the immune system must have some means to detect
‘noninfectious self’ from ‘infectious nonself’. It was already known that presentation of antigens on
MHC class II complex on the surface of antigen presenting cells, namely dendritic cells, was not
enough to convert naïve T cells into effector T cells. Instead, T cells needed a second signal.
Janeway postulated that these PRRs on APCs were able to detect the presence of ‘nonself’ and this
would induce APCs to present co-stimulatory molecules on their surface and these were capable of
providing naïve T cells with the second signal they needed to become activated. At that time, none
of these receptors were known and the idea was purely hypothetical. However, this hypothesis
stimulated much research to identify these kinds of receptors. In 1996, Toll-like receptors of
Drosophila melanogaster (fruit fly) were shown to take part in an anti-fungal response (Lemaitre
et al., 1996). By searching for homologous receptors in humans, the first PRR candidate, named
hToll, was detected in 1997, though its ligand was still unknown (Medzhitov et al., 1997). In 1998,
the gene TLR4 coding  for  hToll,  now  named  as  Toll-like  receptor  4  (TLR4),  was  shown  to  be
mutated in a mouse strain which was unable to respond to the Gram-negative bacteria cell wall
component lipopolysaccharide (LPS) (Poltorak et al., 1998). The final proof that bacterial LPS was
the  ligand  for  TLR4  emerged  in  1999  when  the  mouse  strain TLR4-/- was generated, and it was
shown to be unable to respond to LPS (Hoshino et al., 1999).
These findings shed new light on the innate immune system and its importance for host
immune responses. The innate immune system is an ancient defense mechanism to combat
pathogens. All known life forms possess some kind of innate immunity. The adaptive immune
system is only found in vertebrates, and it was appreciated as a sophisticated solution for
recognizing the vast number of pathogens encountered in nature, because of its ability to produce
millions of different T and B cell receptors able to recognize almost any given structure. The innate
immune system in vertebrates was thought of as an evolutionary remnant whose only task was to
hold the infection in check until “real” immunity, adaptive immunity, kicked in (Medzhitov and
Janeway, 2000). However, T and B cell receptors themselves cannot identify the difference
6between structures derived from pathogens or from host itself. Furthermore, most vertebrate
individuals do not suffer from autoimmune diseases, which are caused by adaptive immune
responses elicited towards self-structures. One reason for this is that during the development of T
cell progenitors in thymus, cells possessing receptors binding too weakly or strongly to self-
structures are eliminated (Bonilla and Oettgen, 2010). However, until the discovery of PRRs the
control of activation of naïve lymphocytes was not fully understood.  Today, it is known that the
innate immune system utilizes the PRRs to send a signal to the adaptive immune system about
when to respond and when to tolerate (Iwasaki and Medzhitov, 2010). In other words, what is
recognized as ‘infectious nonself’ and what is identified from ‘noninfectious self`. In 2011, the
Nobel Prize in Physiology or Medicine was jointly awarded to Jules A. Hoffman and Bruce Beutler
for their work in identifying the first PRRs, Toll-like receptors, and to Ralph M. Steinman for his
discovery of dendritic cells, highlighting the revolution in understanding sparked by PRRs.
To date, four different families of PRRs have been recognized in vertebrates. These are Toll-
like receptors (TLRs), nucleotide-binding domain, leucine-rich repeat containing receptors (NLRs),
RIG-I  like  receptors  (RLRs)  and  C-type  lectin-like  receptors  (CLRs)  (Takeuchi  and  Akira,  2010).
Toll-like receptors and NLRs will be described in detail below. RIG-I like receptors are intracellular
receptors detecting nucleic acids (DNA and RNA) of viruses, and CLRs are transmembrane
receptors recognizing structural constituents of fungi (Takeuchi and Akira, 2010).
1.2.1 Toll-like receptors
Toll-like receptors (TLRs) are the most well known family of PRRs. It has 10 genes in humans
and 12 genes in mice (Takeuchi and Akira, 2010). TLRs are transmembrane receptors surveying the
extracellular space, or the insides of endolysosomes, intracellular vesicles containing endocytosed
substances from outside of cell. All TLRs have N-terminal leucine-rich repeats (LRRs) domain,
transmembrane part, and C-terminal intracellular Toll/IL-1R homology (TIR) domain. The ligands
for TLRs are constituents of bacteria, viruses, protozoa or parasites (Takeuchi and Akira, 2010).
Recently, it has been shown that some TLRs are also able to recognize structures derived from host
self (Piccinini and Midwood, 2010).
The prototypical TLR4 receptor is located on plasma membranes and together with another
transmembrane protein myeloid differentiating factor 2 (MD2), it recognizes Gram-negative
bacteria cell wall component LPS. Plasma membrane protein CD14 and soluble LPS binding
protein (LBP) facilitate the LPS binding to TLR4-MD2-LPS complexes. The TLR4-MD2-LPS
complexes form oligomers, which activate the downstream signaling cascade (Lu et al., 2008).
Ligation of TLRs leads to the activation of transcription of a set of genes related to inflammatory
response. Downstream signaling from TLR4 can proceed through two different pathways. In
myeloid differentiation primary response protein (MyD88)-dependent pathway, TLR4 complexes
remain on the cell surface. As a consequence of the signaling cascade, two transcription factors,
NFκB and AP-1, move from the cytosol to the nucleus where they activate the transcription of
multiple inflammatory genes including those coding for many cytokines. Another signaling
pathway activated by TLR4 ligation leads to the endocytosis of TLR4 complex in endosomal
vesicles. This pathway is called the MyD88-independent pathway. As a result, NFκB, AP-1, and also
transcription factor IRF3 become translocated to the nucleus where they activate the transcription
of multiple genes. IRF3 regulates especially the transcription of type I interferons and interferon-
inducible  genes  (Lu et  al.,  2008;  Takeuchi  and Akira,  2010).  Type I  interferons are  important  in
defense responses especially against virus infection, but they also promote defense responses to
combat bacterial infections (Monroe et al., 2010).
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forming heterodimers with TLR1 and TLR6. Ligands for TLR2/TLR1 and TLR2/TLR6 are various
lipoproteins of bacterial origin. The activation of TLR2/TLR1 or TLR2/TLR6 leads to MyD88-
dependent signaling and the transcription of pro-inflammatory cytokines through activation of
NFκB  and  AP-1  (Takeuchi  and  Akira,  2010).  TLR5  is  expressed  on  the  plasma  membrane  of  a
specialized subpopulation of dendritic cells located in the small intestine. TLR5 recognizes
flagellin, a protein monomer that constitutes bacterial flagella. Three human TLRs are located on
membranes  of  endolysosomes.  These  are  TLR3,  TLR8  (TLR7  in  mouse),  and  TLR9,  which
recognize different nucleic acid structures derived from viruses, bacteria or host itself. The ligand
for TLR3 is viral double-stranded RNA (dsRNA). TLR8 recognizes single-stranded RNA (ssRNA)
usually from RNA viruses, but also from some bacteria. The ligand for TLR9 is unmethylated DNA
with GpC motifs, a nucleic acid structure found in viruses, bacteria and also some protozoa. The
activation of TLR3, TLR8 and TLR9 leads to transcription of pro-inflammatory cytokines and
production of type I interferons through activation of NFκB and IRF3/IRF7 (Takeuchi and Akira,
2010). In contrast to other TLRs, TLR10 was recently found to exert anti-inflammatory properties,
and probably to be able to interact with TLR2 (Oosting et al., 2014).
1.2.2 NLR family of receptors
The identification of membrane-bound TLRs led to the hypothesis that also cytoplasmic
PRRs must exist. The first cytosolic PRRs to be discovered were nucleotide-binding domain,
leucine-rich repeat containing receptors (NLRs). NLRs are a family of intracellular PRRs able to
recognize a wide range of molecular patterns derived from pathogens and endogenous danger
signals. Their discovery originated from studies into the proteins activated during apoptosis, or
programmed cell death. Based on the homology to family of Ced proteins that regulated apoptosis
in a nematode, Caonorhabditis elegans,  the  protein  Apaf-1  was  found  in  vertebrates  (Zou  et  al.,
1997). Apaf-1 has an N-terminal caspase-recruitment domain (CARD) and a centrally located
nucleotide-binding domain (NBD) (Figure 3).  The  C-terminus  of  Apaf-1  possesses  a  domain
containing WD40 repeats (WDR) (Inohara and Nuñez, 2001). After binding to cytochrome c, Apaf-
1 activates caspase-9, which in turn activates caspase-3, the main effector protease during
apoptosis, leading to cleavage of multiple proteins and subsequently to cell death (Li et al., 1997).
Figure 3. The  domain  structures  of  apoptosis-regulating  Apaf-1,  NLR  proteins  NOD1  and  NOD2,  and  R-
proteins found in plants taking part in defense responses.
Soon, two other proteins containing a CARD-domain were identified in vertebrates, named
NOD1  (Bertin  et  al.,  1999;  Inohara  et  al.,  1999)  and  NOD2  (Ogura  et  al.,  2001b).   Like  Apaf-1,
NOD1 and NOD2 have N-terminal CARD-domains (NOD2 has two N-terminal CARDs) and
centrally located NBD-domains (formerly called nucleotide-binding oligomerization domains,
NOD). In contrast to Apaf-1, NOD1 and NOD2 have a domain containing leucine rich repeats
8(LRRs) on their C-terminus. It was soon discovered that NOD proteins have a similar structure as
cytosolic plant resistance (R) proteins. Plant R proteins are membrane-bound and cytosolic
proteins intended to recognize the presence of pathogens. Their activation leads to multiple
defense responses towards pathogen invasion (Dangl and Jones, 2001). The largest class of R
proteins are cytosolic proteins having a centrally located NBD-domain, and C-terminal LRR
domain, similar to the vertebrate NOD proteins. Overexpression of NOD proteins in human cells in
vitro leads to apoptosis, but also to NFκB activation (Bertin et al., 1999; Inohara et al., 1999; Ogura
et  al.,  2001b).  This  observation,  as  well  as  the apparent  homology to  plant  R proteins,  led to  the
suggestion that NOD proteins might be cytosolic receptors for pathogenic ligands, such as LPS
(Ogura et al., 2001b). The transfection of NOD1 and NOD2 to human embryonic kidney 293T cells
was  shown  to  induce  NFκB  activation  when  cells  were  exposed  to  LPS  (Inohara  et  al.,  2001).
Furthermore, a mutation in the NOD2 gene has been shown to be associated with Crohn’s disease,
a chronic inflammatory disease of the gastrointestinal tract, whose pathology has been postulated
to derive from abnormal immune responses towards commensal bacteria found in the gut (Ogura
et al., 2001a). These findings confirmed the hypothesis that NOD proteins were cytoplasmic PRRs
in vertebrates. Today, it is known that the major ligands of NOD1 and NOD2 are peptidoglycan
fragments released from bacterial cell wall. In humans, NOD1 recognizes the tripeptide structure of
peptidoglycan degradation product from Gram-negative bacteria. NOD2 recognizes muramyl
dipeptide (MDP), which is a peptidoglycan component of Gram-negative and –positive bacteria
(Kaparakis et al., 2007).
After the discovery of the NOD proteins, many other proteins having centrally located NBD
domain and C-terminal LRR domains were found in vertebrates, now commonly called as NLRs
(Ting  et  al.,  2008).  In  humans,  22  NLR  genes  have  been  identified  so  far  (Bauernfeind  et  al.,
2011a). They have been renamed and divided into subfamilies based on their domain structure
(NLRA, NLRB, NLRC, NLRP and NLRX subfamilies) (Table 1). They all are crucially involved in
host defense responses upon pathogen invasion and/or tissue damage.
One important subfamily of NLRs is NLRP (NACHT, LRR and PYD domains containing)
proteins, formerly known as NALP proteins. In mammals, the NLRP family consists of 14 proteins.
They are known for their crucial role in promoting inflammation to combat pathogen invasion or in
situations of tissue damage. Inflammation is a powerful defense response, but due to the damage it
potentially does to the host itself, the regulation of inflammation must be tightly controlled. This
regulation is orchestrated by a multiprotein complex called the inflammasome.
Table 1. NLR subfamilies and their known members in humans.
Subfamily Members Domain structure
NLRA CIITA (CARD)-AD-NBD-LRR
NLRB NAIP (BIR)x3-NACHT-LRR
NLRC NOD1 CARD-NBD-LRR
NOD2 (CARD)x2-NBD-LRR
NLRC3 CARD-NBD-LRR
NLRC4 (IPAF) CARD-NBD-LRR
NLRC5 CARD-NBD-LRR
NLRP NLRP1 PYD-NBD-LRR-FIIND-CARD
NLRP2 PYD-NBD-LRR
NLRP3 PYD-NBD-LRR
NLRP4 PYD-NBD-LRR
9NLRP5 PYD-NBD-LRR
NLRP6 PYD-NBD-LRR
NLRP7 PYD-NBD-LRR
NLRP8 PYD-NBD-LRR
NLRP9 PYD-NBD-LRR
NLRP10 PYD-NBD
NLRP11 PYD-NBD-LRR
NLRP12 PYD-NBD-LRR
NLRP13 PYD-NBD-LRR
NLRP14 PYD-NBD-LRR
NLRX NLRX1 X-NBD-LRR
Abbreviations: AD, Acidic activation domain; BIR, Baculovirus inhibitor of apoptosis domain; FIIND,
domain with function to find; CARD, caspase recruitment domain; NACHT, domain present in NAIP, CIITA,
HET-E, and TP-1; NBD, nucleotide binding domain; LRR, leucine rich-repeat domain; PYD, pyrin domain.
Data derived from (Ting et al., 2008).
1.2.3 Inflammasomes
The activation of innate immunity by TLRs and some NLRs (NOD1, NOD2 and CIITA) leads
to changes in transcription of cytokines and chemokines by activating NFκB in host cells (Broz and
Monack,  2013).  However,  the  mechanism  of  activation  of  multiple  NLRs,  including  members  of
NLRP and NLRC subfamily is very different. Their activation leads to assembly of a multiprotein
complex called the inflammasome, which regulates the activation of inflammatory protease
caspase-1 (Man and Kanneganti, 2015). After receiving a signal for activation, distinct NLRs form
oligomers with adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC)
and caspase-1. The ASC consists of a PYD domain and a CARD domain. The PYD domain of ASC
interacts  with  the  PYD  domain  of  NLR,  and  the  CARD  domain  interacts  with  CARD  found  in
caspases. The proximity of several caspase-1 molecules leads to their autocleavage and activation.
Activated caspase-1 then cleaves pro-inflammatory cytokines pro-IL-1β and pro-IL-18 into
biologically active cytokines, which are then readily secreted from the cells and initiate an
inflammatory response (Latz et al., 2013). Importantly, during normal homeostasis, the production
of pro-IL-1β is not activated. Thus the signal detected only through NLRs is not in itself sufficient
to activate the secretion of biologically active cytokines from the cells. Instead, the cell must receive
another signal, which activates the transcription of pro-IL-1β. The transcription of pro-IL-18
remains constant even in resting cells, but it is also enhanced when cells are activated (Latz et al.,
2013). This so called ‘signal one’ activating the transcription of inflammatory cytokines emerges
usually through TLR signaling (Figure 4). Then ‘signal two’ mediated through NLRs enabling the
processing of pro-IL-1β and pro-IL-18 by activated caspase-1 leads to the secretion of biologically
active cytokines (Man and Kanneganti, 2015).
10
Figure 4. Secretion of biologically
active  IL-1β and  IL-18  require  two
distinct signals. Signal one through
PRRs, commonly TLRs, induce the
transcription  of  pro-IL-1β and  in
mice NLRP3 protein. Signal two
provided  by  various  NLRP3
inflammasome agonists such as
ATP or MSU (see the text) induce a
change in the cell which is detected
by  NLRP3 leading  to  the  assembly
of the inflammasome complex
consisting  of  NLRP3,  ASC  and
caspase-1. This assembly leads to
activation of caspase-1 and the
cleavage of pro-IL-1β and pro-IL-
18 to biologically active
forms,which are readily secreted
from the cell.
NLRP1  was  the  first  NLR  reported  to  form  an  inflammasome  (Martinon  et  al.,  2002).
Rupture of human monocytic cell line THP-1 was the signal that resulted in the assembly of the
NLRP1 inflammasome complex consisting of NLRP1, ASC, caspase-1 and caspase-5, another
inflammatory protease, and subsequently to activation of the inflammatory caspases. To date, the
activating ligand for NLRP1 inflammasome has not been conclusively determined, but it has been
postulated to be activated by simultaneous detection of bacterial MDP and host ribonucleoside
triphosphates, such as ATP (Faustin et al.,  2007). It has also been shown that NOD2 and NLRP1
form inflammasome complexes leading to caspase-1 activation upon MDP exposure (Hsu et al.,
2008). In murine macrophages, NLRP1b, a murine subtype, is activated by anthrax lethal toxin
(Boyden and Dietrich, 2006).  Next, NLRP3 inflammasome consisting of NLRP3, ASC and caspase-
1, was characterized (Agostini et al., 2004). To date, multiple signals leading to NLRP3
inflammasome assembly and caspase-1 activation have been characterized. They include
extracellular ATP (Mariathasan et al., 2006); pore-forming toxins (maitotoxin, nigericin
(Mariathasan et al., 2006)); crystallized substances and particles (monosodium urate (MSU),
calcium pyrophosphate dihydrate (CPPD) (Martinon et al., 2006), alum (Li et al., 2008), asbestos
(Dostert et al., 2008), cholesterol crystals (Duewell et al., 2010; Rajamäki et al., 2010), long needle-
like carbon nanotubes (Palomäki et al., 2011), fungal cell wall component 1,3-β-glucans
(Kankkunen et al., 2010), viral RNA (Kanneganti et al., 2006), and DNA (Muruve et al., 2008). The
NLRP3 inflammasome has been the most extensively explored inflammasome, and the list of
agonists activating the NLRP3 inflammasome is the widest set of known for PRR. Interestingly, it
appears that NLRP3 does not interact directly with activating agents, but instead these compounds
induce a change in the cellular environment that is detected by NLRP3 (see 1.3). This explains how
biochemically distinct agents can activate the same inflammasome.
NLRC4 (IPAF) is another NLR able to form an inflammasome. The cytoplasmic bacterial
protein, flagellin, was discovered as the activating agent that assembles the NLRC4 inflammasome,
leading to the activation of caspase-1 (Franchi et al., 2006; Miao et al., 2006). Recently, it has been
shown that NLRC4 inflammasome is activated through ligand detection through another NLR
called NAIP (NLRB). The bacterial type III secretion needle protein is detected by NAIP, which
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then forms a protein complex with NLRC4 called NAIP/NLRC4 inflammasome (Yang et al., 2013).
The most recently characterized inflammasomes are NLRP6, an inflammasome regulating the
interaction between commensal microbes and host mucosal epithelium (Elinav et al., 2011);
NLRP7, an inflammasome activated by microbial acetylated lipopeptides (Khare et al., 2012);
NLRP12, an inflammasome activated during invasion of Yersinia pestis, a bacteria causing a plague
(Vladimer et al., 2012), and NLRP2, an inflammasome expressed in human microglia activated by
extracellular ATP (Minkiewicz et al., 2013). It remains to be seen how many NLRs are able to form
inflammasomes.
In  addition,  proteins  from  other  families  in  addition  to  NLR  are  also  able  to  form
inflammasomes. A member of the PYHIN (Pyrin and HIN domain containing) family, Absent in
melanoma 2 (AIM2) can detect cytoplasmic double-stranded DNA, and subsequently complexes
with ASC and caspase-1 leading to caspase activation (Fernandes-Alnemri et al., 2009; Hornung et
al., 2009). In addition, another member of the PYHIN family, Interferon gamma–inducible protein
16  (IFI16)  has  been  shown  to  form  a  caspase-1  –activating  complex  with  ASC  in  the  nucleus  of
endothelial cells infected with Kaposi sarcoma –associated herpes virus (Kerur et al., 2011). It has
been also revealed that pro-IL-1β can been processed by the noncanonical caspase-8
inflammasome composed of caspase-8, ASC and mucosa-associated lymphoid tissue lymphoma
translocation protein 1 (MALT1) in response to dectin-1 receptor activation by fungi (Gringhuis et
al., 2012).
1.3 RECOGNITION OF ENDOGENOUS DAMAGE MOLECULES BY INNATE IMMUNE
CELLS
The innate immune system utilizes PRRs to detect not only pathogens, but also self-derived
molecules released during tissue damage. These are called danger-associated molecular patterns
(DAMPs) in analogy with PAMPs. In 1994, Polly Matzinger proposed a danger model, which
postulated that the immune system does not discriminate between ‘self’ and ‘nonself’ (Matzinger,
1994). Instead, when the innate immune cells, especially antigen presenting cells, detect
endogenous cellular danger signals derived from damaged cells, they are activated to produce co-
stimulatory signals capable of activating the T cells of adaptive immunity. She even went further to
propose that PRRs might have evolved to detect DAMPs, and subsequently pathogens evolved to
bind to these receptors because this confers survival benefits for the pathogen (Matzinger, 2002).
The danger model provided an explanation why the immune system can be activated in the absence
of pathogens, e.g. after tissue transplantation, in autoimmune diseases and in the presence of some
tumors. There is some debate about certain aspects of the danger model, especially towards the
concept that the immune system would not be able to differentiate between ‘self’ and ‘nonself’
(Janeway Jr et al., 1996; Vance, 2000), but nevertheless tissue damage due to trauma or ischemia
is now known to be a potent activator of innate immune responses also in the absence of
pathogens.
Many endogenous danger signals, or DAMPs, activating innate immune responses have been
identified to date. These are typically intracellular proteins with intracellular functions, or other
substances normally excluded from the extracellular environment. During tissue damage, these
materials are released from the cells, and then they can be recognized as danger signals.
Degradation products from extracellular matrix components might also be endogenous danger
signals (see Table 2.)  (Kono and Rock,  2008).  There  are  certain distinct  receptors  on the innate
immune cells that bind DAMPs, e.g. receptor for advanced glycation end-products (RAGE) for
high-mobility  group  box  1  protein  (HMGB1)  and  P2X  receptors  for  extracellular  ATP.  More
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commonly however, DAMPs seem to be detected by the same receptors as PAMPs, typically with
TLRs (Baker et al., 2005). It is uncertain whether DAMPs possess a common molecular signature
recognized by PRRs in the manner of PAMPs, but a hypothesis has been made that the exposure of
hydrophobic portions (‘hyppos’) normally hidden inside the molecules due to thermodynamic
interactions of molecule and solvent might be the molecular signature that activates the PRRs
(Seong and Matzinger, 2004). The oxidation state of a DAMP might also affect its ability to trigger
the inflammatory response. The environment inside the cell is reducing, but the extracellular
milieu is oxidizing. The oxidation of intracellular proteins after they have been released into the
extracellular environment might misfold or inactivate the protein, thereby changing its ability to
trigger innate immune responses (Carta et al., 2009).
Table 2. Typical danger-associated molecular patterns (DAMPs) activating innate immune
response
DAMP Normal location and
function
Receptor Reference
Intracellular proteins
HMGB1 nucleus, binds to DNA
stabilizing nucleosomes
RAGE, TLR2,
TLR4
(Scaffidi  et  al.,  2002; Lotze and
Tracey, 2005)
HSPs cytoplasm, molecular
chaperones
TLR2, TLR4,
CD14, CD40
(Schmitt et al., 2007)
Galectins cytoplasm, nucleus CD2, CD3,
CD98
(Walzel et al., 2000; Henderson
and Sethi, 2009)
S100
proteins
cytoplasm, Ca-binding,
cytoskeletal
rearrangements
RAGE (Foell et al., 2007)
Other intracellular molecules
MSU cytoplasm, produced in
purine metabolism
lipid rafts (Shi et al., 2003; Ng et al., 2008)
ATP cytoplasm, energy carrier
of the cell
P2X7 (Perregaux and Gabel, 1994; Solle
et al., 2001)
dsDNA nucleus, mitochondrion;
carrier of genetic
information
TLR9 (Hemmi  et  al.,  2000; Ishii  et  al.,
2001)
Extracellular molecules
Hyaluronan extracellular matrix
fragment
TLR2, TLR4,
CD44
(Scheibner et al.,  2006; Taylor et
al., 2007)
Heparan
sulphate
extracellular matrix
fragment
TLR4 (Johnson et al., 2002)
Biglycan extracellular matrix
fragment
TLR2, TLR4 (Schaefer et al., 2005)
Abbreviations: ATP, adenosine triphosphate; dsDNA, double-stranded DNA; HMGB1, high mobility group
box 1; HSP, heat-shock proteins; MSU, monosodium urate
The  detection  of  DAMPs  by  TLRs  and  RAGE  leads  to  the  triggering  of  a  signaling  cascade
resulting in the activation of NFκB and the subsequent production of pro-inflammatory cytokines
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and chemokines. In situations where there is cell damage and necrosis, biologically active pro-
inflammatory cytokines, including IL-1α and IL-33, might also be passively released from the cells
and promote the local inflammation (Chen and Nuñez, 2010). In addition, the detection of some
DAMPs can lead to the activation of the NLRP3 inflammasome, the activation of the inflammatory
caspase-1 and the cleavage of two pro-inflammatory cytokines, pro-IL-1β and pro-IL-18, into
biologically active cytokines. NLRP3 is unique among the known inflammasomes in that it is also
activated by endogenous molecules derived from damaged cells, in contrast to the other
inflammasomes detecting pathogen-derived signals. In spite of extensive research in recent years,
the ultimate ligand detected by NLRP3 leading to the assembly of the inflammasome is still
unknown. The NLRP3 inflammasome has been postulated to be the main sensor for danger in a
cell, and that might be the common theme connecting the various agonists (Schroder et al., 2010).
Release of contents of phagolysosomal vacuole including proteases cathepsins in cytoplasm
(Hornung et al., 2008) and the formation of reactive oxygen species (ROS) (Tschopp and Schroder,
2010) are examples of suggested triggers of NLRP3 inflammasome activation, but to date, only
potassium efflux has been shown to be a common denominator of all agents activating the NLRP3
inflammasome (Muñoz-Planillo et al., 2013).
The current list of known DAMPs and their receptors is likely to be incomplete, and future
research will provide better insights into how DAMPs can activate the innate immune system and
clarify their role in pathogenesis of diseases as well as their synergistic actions with PAMPs (Chen
and Nuñez, 2010).
1.3.1 Monosodium urate
Monosodium urate (MSU) is crystallized uric acid, and it is a well-known DAMP which can
trigger innate immunity. MSU has long been known to be immunostimulatory, since it was
recognized already in 1962 as the causative agent in gout, a metabolic disorder with recurring
inflammation in the joints,  when Faires and McCarthy injected MSU crystals into their knee joints
(Faires and McCarty, 1962). Even though MSU was recognized as the inflammation-inducing agent
in gout, the mechanisms driving the inflammation remained unclear. In 2003, Shi and co-workers
reported that the uric acid released from dying cells was an endogenous danger signal capable of
activating immune responses (Shi et al., 2003). Uric acid stimulated dendritic cells to upregulate
their co-stimulatory molecules, thus providing the second signal to naïve T cells necessary for their
activation, and thus acting in a similar manner as the detection of pathogens through PRRs. In that
study, it was found that the effective concentration of uric acid that stimulated dendritic cells was
the same as that where uric acid started to crystallize. This led the authors to conclude that MSU
crystals were the immunostimulatory form of uric acid (Shi et al., 2003). This meant that MSU was
one of the first DAMPs and also the first endogenous adjuvant to be recognized. More information
of mechanisms how MSU could induce the inflammatory response emerged three years later, when
MSU was found to activate the NLRP3 inflammasome, and subsequent processing and secretion of
the pro-inflammatory cytokines IL-1β and IL-18 (Martinon et al., 2006). It has also been reported
that the immunostimulatory properties of alum, a widely used adjuvant in vaccines, derive from its
ability to release uric acid from the cells (Kool et al., 2008).
There is still no consensus to explain how macrophages and dendritic cells detect MSU.
Initially,  TLR2 and TLR4 were thought  to  recognize  MSU, but  those results  could not  be  verified
later and were explained by the presence of impurities in MSU preparations (Chen et al., 2006). Ng
and co-workers have shown that MSU can associate directly with cholesterol-rich lipid rafts on the
dendritic cell plasma membrane (Ng et al., 2008). The interaction of MSU and plasma membrane
lipids leads to sorting of lipid rafts and activation of Syk tyrosine kinase. Recently, MSU was shown
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to mediate the production of some cytokines including IL-1β from THP-1 cells via P2Y6 receptor -
dependent signaling (Uratsuji et al., 2012). In addition, an inhibitory receptor for MSU has been
recognized. Interactions between MSU with Clec12a, C-type lectin receptor, could reduce MSU-
induced inflammation both in vitro and in vivo (Neumann et al., 2014). Furthermore, it has been
shown that in vivo MSU crystals might be coated with serum proteins including complement
factors and antibodies and these coated crystals might be recognized by the abundant Fc-receptors
and complement receptors present on phagocytosing cells (Shi et al., 2010). However, it is known
that after its recognition, MSU is rapidly phagocytosed inside the cell; this is thought to lead to
phagolysosomal destabilization and the rupture of lysosomal contents into the cytosol (Hornung et
al., 2008) and ultimately to NLRP3 inflammasome activation, although details of mechanism
remain to be resolved.
1.3.2 ATP
Adenosine triphosphate (ATP) is a purine nucleotide. It is a ubiquitous coenzyme in all cells
where it functions as the main carrier of chemical energy for metabolism. The chemical energy in
ATP  is  stored  in  bonds  between  the  phosphate  groups,  and  the  energy  released  upon  bond
breakage is transferred to substrates taking part in metabolic reactions. During normal
homeostasis, the concentration of extracellular ATP is low, since it is rapidly hydrolyzed by ecto-
apyrases and ecto-ATPases (Trautmann, 2009).  Damage to the plasma membrane caused by
pathological conditions, such as pathogen infection, trauma, or ischemia releases cytosolic ATP
into the extracellular environment. This elevation in the local extracellular concentration of ATP is
perceived as a danger signal by the cells of the innate immune system. Extracellular ATP has been
long known for its ability to promote proteolytic maturation and release of IL-1β from murine
macrophages  (Hogquist  et  al.,  1991;  Perregaux  and  Gabel,  1994;  Laliberte  et  al.,  1999).  The
mechanical  explanation  for  this  emerged  in  2006,  when  ATP  was  identified  as  one  of  the  first
agonists which was capable of activating the NLRP3 inflammasome (Mariathasan et al., 2006).
In immune cells extracellular ATP is detected by the P2X7 receptor on the plasma membrane
(Solle  et  al.,  2001).  The P2X7 receptor  is  a  member of  ATP-gated purinergic  P2X receptor  family
ubiquitously expressed in virtually all cells. P2X7 receptor is present in highest amounts in
hematopoietic cells including macrophages, dendritic cells, monocytes and NK-cells, and microglial
cells in the brain. The P2X7 receptor is a ion channel that opens upon ATP binding enabling small
monovalent (Na+,  K+) and divalent (Ca2+, Sr2+ and  Ba2+) cations to move across the membrane
(Wiley et al., 2011). Binding of ATP to P2X7 leads to rapid changes in the ionic balance inside the
cells and this causes major changes in cellular function. The efflux of K+ from  the  cells  is  a
sufficient signal for NLRP3 inflammasome activation (Muñoz-Planillo et al., 2013). The activation
of the P2X7 receptor also exerts other downstream signaling effects. The opening of the P2X7-
activated pore leads to the opening of a larger channel on the plasma membrane, Pannexin-1
(Pelegrin and Surprenant, 2006; Locovei et al., 2007) and this enables larger molecules to pass
through  the  plasma  membrane.  Activation  of  the  P2X7  receptor  leads  to  the  formation  of  ROS,
proliferation, and activation of transcription, reorganization of actin cytoskeleton associated with
membrane blebbing, activation of unconventional protein secretion, and also apoptosis (Wiley et
al., 2011). The P2X7 receptor associates with other proteins on the plasma membrane (Kim et al.,
2001; Gu et al., 2009), and it might be that the composition of the receptor signaling complex
varies between different cell types allowing different downstream signaling events to result from
P2X7 activation (Bartlett et al., 2014). In human macrophages, the receptor complex has not been
characterized.
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1.4 INNATE IMMUNE SYSTEM ACTIVATES ADAPTIVE IMMUNE SYSTEM
The innate immune system is a rapid defense system to combat pathogen invasion and it also
activates mechanisms of tissue-renewal. However, it is not specifically targeted towards any
specific pathogen and it is not able to clear all infections on its own. The adaptive immune system
found in vertebrates mounts defense responses targeted specifically towards individual invading
pathogens. However, it takes longer, many days, before the adaptive immune responses become
activated. Specific adaptive immune responses toward pathogens are mediated by the actions of
lymphocytic T cells and B cells. Innate immune receptors are encoded in genes and thus are similar
in all individuals, but T and B cell recognition of pathogens is mediated through a vast number of
receptors that are variably generated in each individual. The main effector lymphocytes of the
adaptive immune system are helper T cells (Th), cytotoxic T cells, and antibody-secreting B cells.
The adaptive immune system is able to create an immunological memory through the generation of
long-lived T cells and B cells, so that subsequent infection with the same pathogen is either
immediately dealt with, or cleared much faster than during the first encounter (Bonilla and
Oettgen, 2010).
1.4.1 Helper and cytotoxic T cell activation
The innate immune system is responsible for the activation of the adaptive immune system.
Dendritic cells are antigen presenting cells capable of processing antigens from ingested pathogens
and presenting them on plasma membrane proteins, MHCs. Subsequently, the activated dendritic
cells migrate to local lymph nodes where they encounter naïve T cells. In the lymph node there is a
population of T cells with a pool of T cell receptor (TCRs) with different binding affinities derived
from genetic rearrangements of their receptor coding regions. T cells also have two surface
antigens, CD4 or CD8. T cells with CD4 bind to the antigen:MHC class II complex on dendritic cells
through their TCR, if the receptor possesses affinity for the antigen. Similarly, T cells with surface
antigen CD8 bind to the antigen:MHC class I complex on dendritic cells. This binding alone does
not activate the T cell, instead in the absence of other signals, it inactivates them. However, if the
dendritic cell presenting the antigen has received a signal through its PRRs leading to up-
regulation of co-stimulatory molecules on its surface, this provides the T cell with a second signal
through these co-stimulatory molecules and this combination of signals activates the cell. Activated
T cells proliferate, and mature into effector T cells.  CD4+ T cells become helper T (Th) cells,  and
CD8+ T cells cytotoxic T cells (CTLs).  Effector cells are transported to the site of infection in the
blood circulation (Banchereau and Steinman, 1998; Joffre et al., 2009).
At the site of infection antigens derived from pathogens are again presented to T cells, now
effector T cells, through MHC class molecules. MHC class I molecules are expressed on all cells in
the body, and they present antigens derived from cytosol. The presence of pathogen antigens in the
cytosol is evidence of infection in the cell. The incoming CTLs recognize the same antigen that
activated them in lymph nodes, and bind to infected cells, ultimately causing the death of these
targeted cells. MHC class II molecules are only expressed on antigen-presenting cells (dendritic
cells, macrophages and B cells), and they present antigens derived from phagocytosed pathogens.
Macrophages and B cells ingest pathogens to eliminate them. The incoming helper T cells recognize
the same antigen presented on macrophage and B cell MHC class II molecules that activated them
in lymph nodes. This recognition promotes the killing of ingested pathogens by macrophages, and
antigen-specific antibody production by B cells. (Bonilla and Oettgen, 2010; Luckheeram et al.,
2012).
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1.4.2 Th1, Th2 and Th17 type responses
CD4+ Th cells differentiate into subclasses upon activation, based on the environmental cues,
namely which cytokines are present during the activation process. The cytokines that bind to T cells
during their activation are sometimes referred as signal three i.e. signal one being TCR ligation and
signal two representing the co-stimulatory molecules (Joffre et al., 2009). The main Th cell
subclasses  are  Th1,  Th2,  Th17,  and  regulatory  T  cells  (Treg)  (Zhu  et  al.,  2010).  Recently,  new
subclasses Th9 and Th22 have been described (Raphael et al., 2014). The presence of IL-12 and
IFN-γ promotes the development of Th1 cells. Activated Th1 cells secrete IFN-γ themselves
promoting the appearance of a Th1 type environment. The Th1 type response is typically
encountered in intracellular bacterial and viral infections. The differentiation of Th2 type T cells is
driven by two cytokines, IL-4 and IL-2. Th2 type T cells secrete IL-4, IL-5 and IL-13. The Th2 type
response is activated in the presence of parasites, and they have a role in developing allergy and
atopic  illnesses.  The presence of  transforming growth factor  (TGF)-β,  IL-6,  IL-21  and later  IL-23
promotes type Th17 T cell differentiation. Th17 T cells secrete IL-17A, IL-17F, IL-21 and IL-22.
Infection by extracellular bacteria and fungi lead to the appearance of Th17 responses (Zhu et al.,
2010;  Luckheeram  et  al.,  2012;  Raphael  et  al.,  2014).  Th17  cells  together  with  Th1  cells  are  also
involved in the generation of autoimmune diseases (Damsker et al., 2010). In contrast to other
subpopulations of Th cells, Treg cells are anti-inflammatory. These Treg cells mature in the
presence of TGF-β and IL-2, and secrete TGF-β and IL-10, which are responsible for a suppression
of immune responses (Shevach, 2009).
1.4.3 B cell activation
B cells have receptors on their cell surface called B cell receptors (BCR), which are membrane
bound immunoglobulins. Similar to the situation in naïve T cells, there is also a population of naïve
B cells which have a variety of BCRs with different binding affinities. Ligation of a pathogen to BCR
leads to internalization of the receptor and the presentation of pathogen-derived antigens on MHC
class II receptors. Some antigens are able to activate B cells without any help from Th cells. In the
majority  of  cases  however,  in  order  to  achieve  maximal  B  cell  activation,  help  is  required  from
effector Th cells recognizing the same antigen. Activated B cells start to secrete large amounts of
soluble immunoglobulins (first IgM, then IgG, IgA, IgE), antibodies, with similar binding affinities
and similar potentials as the BCRs to recognize the pathogen (Bonilla and Oettgen, 2010).
1.5 INNATE IMMUNE SYSTEM IN HEALTH AND DISEASE
1.5.1 Aberrations in innate immune response
Disturbances of the innate immune system are involved in the pathogenesis of many different
diseases.  Aberrations leading to  disorders  may be caused by mutations in  one gene only,  or  they
may have a more complex genetic background. Typical syndromes in which only one gene is
mutated include autoinflammatory syndromes, or periodic fever syndromes, where recurrent
inflammation occurs without infections. Cryopyrin-associated periodic syndromes (CAPS) are
syndromes where putative gain-of-function mutations in NLRP3 gene lead to the spontaneous
assembly of the NLRP3 inflammasome and unregulated production of the pro-inflammatory
cytokine, IL-1β, causing inflammatory symptoms like fever, rash and pain (Hoffman and Brydges,
2011). Syndromes included in the CAPS family are Muckle-Wells syndrome (MWS), familial cold
autoinflammatory syndrome (FCAS) (Hoffman et al., 2001) and chronic infantile neurologic
17
cutaneous and articular syndrome (CINCA) (Aksentijevich et al., 2002). Another periodic fever
syndrome is familial Mediterranean fever (FMF), where recurrent inflammation occurs due to a
mutation of the gene MEFV coding  for  the  protein  Pyrin.  Pyrin  is  a  protein  whose  function  in
inflammation has not been characterized in detail. It is thought to either negatively regulate
inflammasome activation or activate IL-1β production (Bernot et al., 1997; Chae et al., 2006).
Inflammatory bowel diseases (IBD) and spondyloarthropathies (SpA) are examples of
diseases whose pathology has a strong innate immune system component and whose pathogenesis
is affected by multiple genes. Inflammatory bowel diseases (Crohn’s disease and ulcerative colitis)
are chronic inflammatory disorders of the gastrointestinal tract. They are characterized by mucosal
inflammation and ulceration in the presence of activated inflammatory cells and inflammatory
mediators in lamina propria and the crypts (Xavier and Podolsky, 2007). NOD2 was the first gene
linked to Crohn’s disease (Ogura et al., 2001a).  Subsequently other genes like IL23R coding for
receptor for IL-23 indicative of the involvement of type Th17 responses, NFC4 coding  a  NADPH
oxidase component p40Phox needed to generate the oxidative burst in phagocytosing cells and
CARD9 that codes for protein involved in NFκB signaling events were shown to be susceptible
genes for Crohn’s disease (Xavier and Podolsky, 2007; Reveille, 2012). In addition, a recent report
has shown that mice deficient in NLRP6 displayed an increased susceptibility to suffer colitis
(Elinav  et  al.,  2011).  The  pathogenesis  of  IBD  is  now  thought  to  involve  interactions  between
commensal bacteria in the gut and the host. The host treats commensal bacteria as pathogenic, and
elicits defense responses, causing persistent inflammation, ultimately leading to damage in the gut
(Xavier and Podolsky, 2007).
Spondyloarthropathies (SpA) are a group of closely related rheumatic diseases including
ankylosing spondylitis, reactive arthritis (ReA), psoriatic arthritis, enteropathic-related spondylitis
and arthritis, and undifferentiated SpA (van Tubergen and Weber, 2012). The symptoms of all SpA
are heterogenous, but inflammation of axial skeleton, and peripheral arthritis are rather typical.
However, there might also be extra-articular symptoms such as uveitis, psoriatic skin lesions and
gut inflammation that might lead to IBD. It is known that there is a connection between gut
inflammation and SpA, but the molecular mechanisms are still unraveled (Van Praet et al., 2012).
ReA is the only subtype of SpA where the link of inflammation in gut and joint has been shown so
far. ReA is a sterile joint inflammation following an infection of gastrointestinal or urogenital tract
by bacteria like Yersinia enterocolitica, Salmonella typhirium, or Chlamydia trachomatis (Baeten
et  al.,  2002;  Hannu,  2011).  All  SpAs  are  strongly  associated  with  a  subtype  of  the  MHC  class  I
molecule called HLA-B27, but recently other genetic factors has been identified including IL23R,
ERAP1, IL12B, STAT3 and CARD9.  SpA  share  a  partly  similar  genetic  background  with  IBD
suggesting that similar pathogenic mechanisms are involved in both disorders (Reveille, 2012).
Autoimmune diseases are disorders where the immune system is activated to elicit a defense
against self-antigens. The effector mechanisms of autoimmune diseases are typically adaptive
immune responses, but the initial triggers leading to the appearance of autoreactive T cells and
generation of autoantibodies are commonly not known. Genetic factors are known to predispose to
autoimmune diseases, but environmental factors including infections are also likely to be involved
in the generation of the diseases (Doria et al., 2012). The innate immune system appears to have a
role in the pathogenesis of these diseases, since it activates adaptive immune system (Waldner,
2009). In particular, there are indications that NLRP3 inflammasome and the production of IL-1β
are involved in the development of some autoimmune diseases like type 1 diabetes (T1D) and
multiple sclerosis (MS) (Dinarello and van der Meer, 2013; Coll et al., 2015).
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1.5.2 NLRP3 inflammasome and metabolic disorders
Innate immune responses have been linked with the pathogenesis of multiple, if not all,
inflammatory diseases. Gout is a metabolic disease characterized by high serum levels of uric acid,
a condition called hyperuricemia, and there is evidence of deposits of crystallized uric acid,
monosodium urate (MSU) in the synovial joints and associated tissues (Perez-Ruiz et al., 2015). In
humans, uric acid is the end-product or metabolic degradation of purines, and its levels are
regulated by excretion mainly through the kidneys. Genetic factors, gender, diet, and drugs like
diuretics are all factors that influence the development of hyperuricemia, but in the majority of
subjects with gout, uric acid clearance is impaired (Doherty, 2009). Gout develops through the
nucleation and formation of MSU crystals in joints and associated tissues after prolonged periods
of hyperuricemia exceeding the solubility of uric acid. In particular, the joint of the big toe, but also
other synovial joints such as the ankles, knees, fingers, and wrists might be affected (Doherty,
2009). If hyperuricemia persists, gout progresses from non-symptomatic crystal formation to
recurrent self-limiting inflammatory flares in those sites where there are crystal deposits, and
finally to chronic inflammation gouty arthritis, that can cause physical damage to the joints (Perez-
Ruiz et al., 2015).
The pathogenesis of gout was linked to MSU already in 1962 (Faires and McCarty, 1962), but
its mechanism of inducing inflammation was only resolved in 2006, when Martinon et al.
discovered that MSU activated the NLRP3 inflammasome in human and murine macrophages,
leading  to  IL-1β and  IL-18  processing  and  secretion  (Martinon  et  al.,  2006).  Furthermore,  IL-1
receptor signaling has been shown to be essential in MSU-induced inflammation (Chen et al.,
2006), and gouty inflammation can be effectively treated with IL-1 blockade by treatment with an
IL-1 receptor antagonist (So et al., 2007). Thus gout is an inflammatory disorder whose pathology
is strongly driven by activation of innate immune responses, specifically the NLRP3
inflammasome. Interestingly, the excessive activation of the NLRP3 inflammasome by MSU in gout
does not lead to autoimmune responses even though a profound inflammation is elicited. This
suggests that the innate immune system has some mechanism to allow for the separation of the
signals derived from danger and those originating from pathogens, and in principle adaptive
immune system should be recruited only upon encounters with pathogens. However, these
mechanisms remain largely uncharacterized (Iwasaki and Medzhitov, 2010).
NLRP3 inflammasome activation has also been linked to other metabolic disorders, like
atherosclerosis and type 2 diabetes (T2D) (Robbins et al., 2014). Atherosclerosis is a disease where
deposits of cholesterol accumulate along the arterial wall. Over time, atherosclerotic lesions are
formed consisting of phagocytosing macrophages recruited to the site and crystalline cholesterol
released from ruptured macrophages. In 2010, it was shown that cholesterol crystals could activate
the NLRP3 inflammasome, providing a direct link between NLRP3 activation and atherosclerosis
(Duewell et al., 2010; Rajamäki et al., 2010). T2D is a disease characterized by hyperglycemia,
insulin resistance and chronic inflammation at the systemic level. IL-1β has been shown to
contribute to the pathogenesis of the disease, but the exact mechanisms have not been clarified
(Robbins  et  al.,  2014).  However,  islet  amyloid  polypeptide  (IAAP)  which  is  capable  of  forming
amyloid deposits in the pancreas of T2D patients, has been shown to be able to activate the NLRP3
inflammasome (Masters et al., 2010).
1.5.3 P2X7 receptor in human disease
The receptor for extracellular ATP, P2X7 has been associated with many inflammatory
diseases. The role of P2X7 on innate immune responses towards intracellular bacteria and
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parasites has been widely recognized. P2X7 receptor stimulation induces killing of intracellular
bacteria Mycobacterium tuberculosis (Lammas et al., 1997; Fairbairn et al., 2001; Kusner and
Barton, 2001) and Chlamydia trachomatis (Coutinho-Silva et al., 2003) in macrophages. P2X7
receptor activation is able to eliminate intracellular pathogens via the induction of phospholipase
D, fusion of lysosomes to pathogen-containing phagosomes and death of infected macrophages.
Multiple polymorphic variants of the gene encoding for P2X7 (P2RX7) have been characterized in
humans with single nucleotide polymorphisms (SNPs) producing either gain-of-function or loss-of-
function mutations (Wiley et al., 2011). Certain SNPs leading to loss-of function variants of P2RX7
have been linked to increased susceptibility to M. tuberculosis (Miller et al., 2011a; Wiley et al.,
2011). Similarly, the elimination of intracellular parasite Toxoplasma gondii in macrophages has
been  shown  to  be  mediated  through  P2X7  receptor  signaling  (Lees  et  al.,  2010).  Furthermore,
macrophages from humans with the SNP variant of P2RX7 leading to a loss-of-function mutation
were less effective in eliminating T. gondii upon ATP exposure (Lees et al., 2010).
P2X7-mediated signaling is essential in the activation of the adaptive immune responses in
multiple settings. P2X7 receptor signaling has been shown to be involved in the development of the
serious allergic disease, contact hypersensitivity, as P2X7-deficient dendritic cells were unable to
induce sensitization of contact allergens (Weber et al., 2010). Furthermore, graft-versus-host-
disease was clearly attenuated upon ATP neutralization, pharmacological blockade of P2X7
receptor,  or  deficiency  of  P2X7  receptor,  highlighting  the  role  of  P2X7-mediated  signaling  in
development of immune-mediated tissue destruction (Wilhelm et al., 2010). Furthermore, P2X7-
deficient dendritic cells were unresponsive to stimulation with tumor cells, and this resulted in
complete loss of antitumor responses and significantly enhanced tumor growth in P2X7-deficient-
mice (Adinolfi et al., 2015).
Certain SNP variants of the P2RX7 have even been linked to mental disorders like bipolar
disorder  (McQuillin  et  al.,  2008)  and  major  depressive  disorder  (Lucae  et  al.,  2006).  There  is
emerging evidence for a link between depression and inflammation (Dantzer et al., 2008), and it
has been speculated that possessing the genetic variant of the high-functioning P2X7 receptor
might predispose the individual to depressive behavior (Stokes et al., 2010).
1.6 PROTEIN SECRETION IN IMMUNE RESPONSES
Cells secrete proteins to signal with their environment. Signaling is referred to as autocrine
signaling if the cells themselves possess the receptors that detect the secreted substances. However,
for all multicellular organisms, the signaling between cells, paracrine signaling, is of vital
importance. The effector cells of innate immunity, macrophages and dendritic cells signal to other
cells by secreting anti- and pro-inflammatory cytokines, and chemokines to recruit other
inflammatory cells to the appropriate site. Macrophages also secrete growth factors, enzymes, and
other proteins like proteinases which are able to reform the extracellular matrix (Gordon et al.,
2014).
1.6.1 Conventional protein secretion
Protein secretion is mediated through two distinct routes. Conventional protein secretion
refers to protein trafficking through endoplasmic reticulum (ER) and Golgi apparatus before their
release into the extracellular space. Conventional protein secretion was described already in 1975
(Palade, 1975), and is now fairly well characterized. Proteins destined to be secreted through
conventional protein secretion pathway have an N-terminal signal peptide, which is 13-36 residues
long amino-acid sequence. Conventionally secreted proteins are transported to the lumen of ER
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during their translation. This is mediated by signal peptide recognition by signal recognition
particle (SRP). SRP binds to the growing polypeptide-ribosome complex, arrests the translation
and then the complex travels to the membrane of rough ER where translation of mRNA continues.
The growing polypeptide is shuttled into the lumen of the ER through a transmembrane pore called
the translocon. When the synthesis of polypeptide is finished, it is released from the ribosome and
the translocon to the lumen of the ER. From there, the secretory proteins are transported in COPII-
coated vesicles that bud off at ER and fuse with the cis cisternae of the Golgi apparatus. They travel
through the Golgi apparatus in vesicles from cis to medial to trans cisternae. In the trans network
of the Golgi apparatus, secretory proteins are packed into secretory vesicles, which are transported
to the plasma membrane. Vesicles may either be stored to be released only after receiving the
appropriate stimuli, or they may be constitutively fused with the plasma membrane prior to release
of the proteins into the extracellular space.
The majority of inflammatory cytokines and chemokines, such as IL-6, TNF and CXCL8 are
transported through the conventional secretory pathway (Eder, 2009). However, some secretory
proteins lack a signal peptide and are not transported through ER and Golgi apparatus. Secretion
of these non-signal peptide containing proteins is mediated through other routes, collectively
termed as unconventional protein secretion pathways.
1.6.2 Unconventional protein secretion
Unconventional protein secretion consists of different strategies for the secretion of proteins
lacking a signal peptide, or leaderless proteins. The detailed molecular mechanisms of various
trafficking systems are not fully characterized, but non-vesicular and vesicular pathways of
unconventional protein secretion can be distinguished (Rabouille et al., 2012). Furthermore,
unconventional protein secretion can be divided into four classes (Figure 5).
Figure 5. Unconventional protein secretion pathways. Type I pathway is non-vesicular trafficking of
proteins  directly  through  the  lipid  bilayer.  The  secretion  of  protein  fibroblast  growth  factor  2  (FGF2)  is
mediated  through  a  type  I  pathway  (Rabouille  et  al.,  2012).  The  type  II  pathway  is  also  a  non-vesicular
secretion  pathway  involving  ABC  transporters  spanning  the  plasma  membrane  (Rabouille  et  al.,  2012).
Proteins secreted through the type III pathway of unconventional secretion are packed into vesicles at some
stage of their trafficking. Proteins might be transported in intracellular vesicles such as secretory lysosomes
and  autophagosomes  that  fuse  with  the  plasma  membrane  and  release  their  protein  content  into  the
extracellular space. Proteins might also be packed in multivesicular bodies (MVBs) containing vesicles called
exosomes, which are released outside the cell when MVBs fuse with the plasma membrane. Finally,
microvesicles might be shed directly from the plasma membrane and they may have soluble intracellular
proteins  inside  their  lumen  (Nickel  and  Rabouille,  2009;  Rabouille  et  al.,  2012).  Type  IV  pathway  of
unconventional secretion includes variations from the conventional pathway. Here, the proteins budding off
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from endoplasmic reticulum (ER) are transported directly to the plasma membrane passing the trafficking
through  the  Golgi  apparatus.  All  of  the  proteins  known  to  be  secreted  this  route  are  integral  membrane
proteins, and thus are not released into the extracellular environment (Rabouille et al., 2012).
1.6.3 Extracellular vesicles in immune responses
Cells were found to secrete vesicles already in the 1960’s when the first images of vesicles
secreted from platelets were taken with the electron microscope (Wolf, 1967). The exosomes were
described in 1980’s when the transferrin receptor was shown to be exocytosed within small vesicles
from maturing sheep reticulocytes (Harding et al., 2013). In recent years, extracellular vesicles
(EVs) have been extensively investigated. It has been postulated that possibly all cell types are able
to secrete EVs, and vesicles can transport proteins and RNA to other cells and this represents an
important form of cell-cell communication (Thery et al., 2009; György et al., 2011).
Three main types of EVs can be characterized e.g. exosomes, microvesicles and apoptotic
bodies (see Table 3.). Other subtypes of vesicles have also been described, i.e. retrovirus-like
particles (90-100nm; (Akers et al., 2013)), membrane particles (50-80 nm, 600nm; (Thery et al.,
2009;  van  der  Pol  et  al.,  2012)),  ectosomes  (50-200  nm;  (Thery  et  al.,  2009))  and  exosome-like
particles (20-50 nm; (Thery et al., 2009)). EVs are a heterogenous group and since they have only
recently been described, the nomenclature and classification of extracellular vesicles have not been
standardized yet (Witwer et al., 2013). In addition, the characteristics of the subclasses tend to
overlap, and in practice all the isolated preparations of EVs contain more than one type of vesicle,
making  it  difficult  to  define  specific  markers  for  their  identification  (van  der  Pol  et  al.,  2012;
Witwer et al., 2013). However, exosomes are the only subclass known to be released from
multivesicular bodies, whereas other extracellular vesicles including microvesicles form by
blebbing from the plasma membrane (Thery et al., 2009; Akers et al., 2013).
Table 3. Characterization of main population of extracellular vesicles
Size
Size range
overlapping
with Cellular origin Density
Typical
protein
markers
Exosomes 50-100
nm
viruses Exocytosis of
multivesicular bodies
1.13-1.19
g/ml
Alix, TSG101,
CD63, CD9,
MHC
molecules,
HSPs, actin,
tubulin
Microvesicles 100-
1000 nm
bacteria,
protein
aggregates
Shedding of plasma
membrane
not known β-integrins,
VAMP3, actin,
tubulin,
selectins
Apoptotic
vesicles
100-
5000 nm
platelets Released during
apoptosis
1.16-1.28
g/mol
histones
Data taken from (Thery et al., 2009; György et al., 2011; Buzas et al., 2014)
Evidence has started to emerge of the role of EVs in the immune response. EVs released from
antigen presenting cells have been shown to carry MHC class I and MHC class II molecules, co-
stimulatory molecules and adhesion molecules indicating that they are able to stimulate T cells
(Robbins and Morelli, 2014). Furthermore, EVs have also been shown to transfer antigens between
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dendritic cells. EVs released from mature dendritic cells containing MHC molecules and bound
antigens can be internalized by the immature dendritic cell, which then processes the antigen and
presents it on its own MHC molecules (Robbins and Morelli, 2014). Antigens released directly in
EVs from pathogen-infected cells and tumor cells might be also internalized by dendritic cells for
antigen presentation on MHC class II and MHC class I molecules activating CD4+ and CD8+ T
cells  (Robbins  and  Morelli,  2014).  Furthermore,  EVs  have  been  shown  to  carry  many  of  the
autoantigens associated with autoimmune diseases like heat shock proteins (HSPs), histones, DNA
and RNA indicating that EVs might be involved in the generation of autoimmune diseases, but the
detailed mechanisms have not been elucidated (Buzas et al., 2014).
EVs may also have a role in inflammation. The inflammatory cytokine IL-1β is a well-known
example of a secretory protein lacking a signal peptide, and its trafficking has been proposed to
involve multiple vesicle-mediated protein secretion pathways, including EVs (Eder, 2009). Its
secretion has been reported to be mediated by exocytosis of secretory lysosomes (Andrei et al.,
1999) and also by exocytosis of autophagic vacuoles (Dupont et al.,  2011). It has been detected in
microvesicles shed from plasma membrane (MacKenzie et al., 2001; Bianco et al., 2005; Pizzirani
et al., 2007), and in exosomes released from cells (Qu et al., 2007). IL-1β has also been thought to
be trafficked through some undefined plasma membrane transporter, and it has been released after
lysis of necrotic cells (Eder, 2009; Cullen et al., 2015). HMGB1, a well-known DAMP, is another
classical example of a protein secreted unconventionally. During necrosis, it is released from cells
by exocytosis of lysosome-like vesicles (Gardella et al., 2002) or autophagic vacuoles (Dupont et al.,
2011), but during apoptosis, it has been detected in EVs which were defined as apoptotic vesicles
(Schiller et al., 2013).
Caspase-1, which is a part of the inflammasome complex, is suggested to regulate
unconventional protein secretion (Keller et al., 2008). Its activation by the inflammasome induces
the secretion of caspase-1 itself and other inflammasome components such as NLRP3 and ASC, as
well as its substrates IL-1β and IL-18 into the extracellular space (Martinon et al., 2006; Hornung
et al., 2008; Muñoz-Planillo et al., 2013). In addition, activation of caspase-1 regulates the
secretion of other proteins lacking a signal peptide that are not its substrates, e.g. HMGB1, IL-1α
and FGF-2 (Keller et al., 2008; Lamkanfi et al., 2010; Groß et al., 2012). It has even been suggested
that the presence, not the proteolytic activity, of caspase-1 is required in unconventional secretion
of some proteins, like IL-1α (Groß et al., 2012). Intriguingly, there are recent reports claiming that
after NLRP3 inflammasome activation, the complex itself is caspase-1-dependently released from
the cells into the extracellular space as a functional oligomeric particle, or an ASC speck, which is
able to activate caspase-1 not only in the extracellular space but also in other macrophages that
internalize the particle (Baroja-Mazo et al., 2014; Franklin et al., 2014). It remains to be resolved
how caspase-1 regulates unconventional protein secretion, and what types of EV, if any, are
involved.
1.7 PROTEOME RESEARCH
Proteins  are  responsible  for  majority  of  functions  performed  by  the  cells.  Proteins  are
crucially involved in all major biological processes like metabolism, defense, transport,
reproduction, and they also serve as structural components of the cell. The gene is a sequence of
DNA bases containing the information about the amino acid sequence of a polypeptide that forms a
protein. The gene is used as a template for transcribing mRNA, which is translated into the
polypeptide, which folds into three-dimensional structure of a protein by itself or in combination
with other polypeptides. However, the abundance of mRNA-species in a given occasion does not
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correlate well with the abundance of the corresponding protein. This is due to several reasons e.g.
regulation of translation efficiency, variable protein half-lives, the existence of untranslated mRNA
species, and experimental biases (Maier et al., 2009). In addition, in humans the majority of
mRNA species are also processed with alternative splicing, which makes it possible to produce
multiple proteins from a single gene (Wang et al., 2008). Furthermore, proteins can also be post-
translationally modified by addition of chemical groups. The most common post-translational
modifications include phosphorylation, ubiquitination, glycosylation or lipidation (Deribe et al.,
2010). This creates a huge diversity of proteins in comparison to the numbers of mRNA-species or
genes. It has been estimated that humans have 20 300 genes, which give rise to approximately
1 000 000 species of proteins (Gstaiger and Aebersold, 2009). Therefore, to obtain a realistic view
of what proteins and how much of them are expressed in a cell, proteins have to be studied directly.
Cells are literally full of proteins and it is the interactions between multiple proteins rather
than the simple abundance of individual species of proteins that dictates the outcome of reactions.
To gain insight of how biological systems actually work, tools have been created that enable
monitoring of multiple components of the system simultaneously. Proteomics is the research
examining collections of proteins, the proteome, in a given cell, cell organelle, or tissue, in a certain
physiological state. It is analogous to transcriptomics, which is the research of all expressed genes
in the form of mRNA in given cell or tissue under a certain physiological state. Proteome studies
consist of the identification and quantification of proteins, as well as the analysis of their post-
translational modifications (Bensimon et al., 2012).
1.7.1 Biological mass spectrometry (MS) in proteomics
Proteins have been traditionally investigated with different techniques based on the
exploitation of antibodies specific for the protein in question. However, in these approaches, the
availability of the antibody can often become the limiting factor. Furthermore, it might be difficult
to quantify accurately the signal produced by antibody-based approaches (Choudhary and Mann,
2010). Within the past decades, system-wide proteome studies have become possible due to
advances in mass spectrometry (MS) technology. MS is a method of measuring accurately the
mass-to-charge ratio of various analytes (Walther and Mann, 2010). The analytes must be present
in the gas-phase and they must have a charge. The lack of suitable ionization methods for large
biomolecules such as proteins hampered the application of MS in protein research for a long time
(Fenn et al., 1989). The discovery of soft ionization techniques called electrospray ionization (ESI)
(Fenn et al., 1989), and matrix-assisted laser adsorption ionization (MALDI) (Karas and
Hillenkamp, 1988) allowed peptides and proteins to be ionized into the gas-phase without suffering
extensive degradation has enabled the development of biological MS. It was not only the
development of soft ionization techniques that led to the rapid growth of MS-based proteomic
studies, but also technological breakthroughs in sample preparation, instrumentation and data
analysis have resulted in today’s situation where mass spectrometry –based proteomics represent a
powerful tool in biological research (Meissner and Mann, 2014). The importance of soft ionization
techniques in biomedical protein research is highlighted by the fact that the Nobel Prize in
Chemistry was jointly awarded in 2002 to John B. Fenn for the development of ESI, and to Koichi
Tanaka for the development of a method leading to MALDI. Biological MS-based proteomics have
developed so rapidly that in 2014 the first drafts of the human proteome were published (Kim et
al., 2014; Wilhelm et al., 2014).
The most common approach used in proteomic studies is called a bottom-up, or shotgun
method. A typical workflow of a bottom-up proteomics study is depicted in Figure 6. The bottom-
up approach usually starts with the separation of proteins. In proteomic studies, the samples to be
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analyzed are typically a complex mixture of proteins that vary in their dynamic range by as much as
1010, especially in clinical samples (Anderson and Anderson, 2002). Proteins present in low
amounts are difficult to detect if they have to be analyzed together with abundant proteins. First,
proteins need to be separated e.g. by running them on sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) gel. Subsequently, the proteins are enzymatically digested, usually
with trypsin. The digestion phase produces a multitude of peptides, which might again need to be
separated e.g. with liquid chromatography before their analysis with MS. In proteomic studies,
tandem MS (MS/MS) is commonly used, where masses of intact peptides are measured in the first
MS, and the masses of fragmented peptides are measured in the second MS (Yates et al., 2009).
Figure 6. Bottom-up proteomic study workflow. ESI, electrospray ionization; MS, mass spectrometry; m/z,
mass-to-charge ratio.
Based  on  the  MS/MS  spectrum  of  fragmented  peptide,  the  protein  yielding  it  can  be
identified by searching through some protein database, usually UniprotKB/SwissProt (Choudhary
and Mann, 2010). The database searches are done with search engines like SEQUEST, Mascot or
X!Tandem. The search algorithm consists of four stages. In the first stage, the database of proteins
are virtually digested with the enzyme used, e.g. trypsin. Then theoretical peptides are filtered to
include only peptides with similar masses as those observed. Then the fragmentation patterns of
filtered peptides are predicted. Finally, theoretical fragmentation patterns are compared to
observed fragmentation patterns of peptides, and scores are assigned to evaluate the quality of the
match (Ytterberg et al., 2010). The quality of identification results can be estimated by deducing
the false discovery rate (FDR). The estimation of the FDR can be calculated by searching the raw
data against a decoy database, which is a random or reverse of the original database and should not
ideally give any identifications, and then counting the number of false identifications derived from
the decoy database (Elias and Gygi, 2007).
In addition to protein identification, protein quantification is of importance in proteome
studies. Previously, the combination of 2-dimensional electrophoresis (2-DE) and subsequent
identification with MS was the most commonly used method for the quantification of proteins. In
2-DE, the proteins are first in-gel separated according to their isoelectric point, pI. Then, proteins
are subjected to SDS-PAGE to separate them further by their molecular weight. Subsequently, the
proteins in gel are visualized by staining. The analysis of intensities of protein spots is conducted by
computerized image analysis, which makes a comparison of protein intensity patterns from
different treatment groups. The proteins can then be cut out of the gel prior to their identification
by  MS  (Görg  et  al.,  2004).  2-DE  has  certain  limitations,  such  as  the  poor  representation  of
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membrane proteins due to their low solubilization properties, and the inherent difficulties to
analyze proteins with very low or high molecular weights (Görg et al., 2004).
Nowadays, biological MS is commonly used for simultaneous identification and
quantification of proteins. The relative quantification by MS can be done by comparing intensities
of  signals  derived  from  different  treatment  groups.  This  requires  the  labeling  of  the  proteins  or
peptides before their analysis, and by pooling and analyzing them together to reduce technical
variations in sample preparation and analysis. SILAC (stable isotope labeling of amino acids in cell
culture) is a widely used technique of metabolic labeling in proteomic studies, where cells are
grown in media containing arginine and lysine labeled with 13C and/or 15N making their proteins
heavier than those of cells grown with conventional 12C and 14N.  Signals  derived  from  the  two
groups to be compared can then be distinguished by their slightly differing masses (Choudhary and
Mann, 2010). iTRAQ (isobaric tag for absolute and relative quantification) is an example of a
chemical labeling method, where labels are inserted into the amino groups of lysine-residues and
N-terminus of peptides. Labeled peptides have equal masses (isobaric), but during peptide
fragmentation, the labels produce reporter ions enabling the amounts of peptides from different
treatment groups to be quantified (Bantscheff et al., 2012). Label-free techniques of determining
the relative quantifications have also been developed. They are technically more challenging, but
nowadays provide robust and powerful alternatives to the labeling methods that have inherently
more biases and variations attributable to sample handling (Choudhary and Mann, 2010; Meissner
and Mann, 2014).
The identification and quantification results obtained from a proteomic experiment might
include thousands of proteins, and their analysis requires bioinformatics and computational
methods to yield biologically meaningful results. The bioinformatic tools developed for analyzing
gene expression data can be commonly applied for analyzing proteomics data, although some
proteomic applications like the elucidation of post-transcriptional modifications require separate
analytical tools (Malik et al., 2010). Gene Ontology (GO) classifications which utilize cellular
component, biological process, and molecular function to categorize proteins in a dataset are a
common method for describing the data (Ashburner et al., 2000). Retrieved GO-terms can then be
analyzed to find GO-terms that are overrepresented within the data (Schmidt et al., 2014). There
are  multiple  freely  available  tools  for  these  purposes,  e.g.  GoMiner  (Zeeberg  et  al.,  2003),
GeneTrail (Backes et al., 2007), and DAVID (Huang et al., 2008), and also commercial products
like Ingenuity Pathway Analysis (IPA, Qiagen, www.qiagen.com/ingenuity). Many of these tools
also provide an analysis of enriched pathways encountered in the data. Pathways are defined as a
set of reactions among biomolecules leading to some specific outcome in the cell (Malik et al.,
2010). Overrepresentation of proteins taking part or regulating the reactions of some certain
pathway extracted from the data might be analyzed. Pathway enrichment analysis thus provides
information about the functional and physical interactions between proteins in the data, and might
be  even  more  informative  than  analysis  of  GO  terms  (Malik  et  al.,  2010;  Schmidt  et  al.,  2014).
KEGG (Kanehisa et al., 2014) and Reactome (Croft et al., 2014) are examples of pathway databases
used in analyses. Visualization of the pathways and interactions of proteins can be done with a
graphical tool like Cytoscape (Shannon et al., 2003). Furthermore, different tools have been
developed to allow more specific analysis of the data. These include SignalP (Petersen et al., 2011),
which predicts if the proteins in the data have a signal peptide i.e. it provides information about the
secretion pathway that should be utilized by the protein.
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1.7.2 Proteomics in innate immune research
 In recent years, proteomics have been increasingly applied for elucidating innate immune
responses. The literature contains reports of the characterization of whole cell proteome changes,
e.g. in study conducted by Reales-Calderón and co-workers, where they infected human primary
macrophages of types M1 and M2 with Candida albicans, and compared the differences in
intracellular proteins (Reales-Calderón et al., 2014). Post-translational modifications have also
been studied, e.g. by Sjoelund and co-workers, where changes in phosphorylation patterns of
proteins, or the so-called phosphoproteome, were studied in immortalized murine macrophages
upon activation with different Toll-like receptor agonists (Sjoelund et al., 2014). Some studies have
focused on proteome changes in distinct organelles upon activation of the cells (Härtlova et al.,
2014; Dill et al., 2015). A few secretome characterizations from innate immune cells have also been
conducted. The secretomes of human primary macrophages exposed to influenza A virus (Lietzén
et al., 2011), herpes simplex virus-1 (Miettinen et al., 2012), 1,3-β-glucans (Öhman et al., 2014) and
carbon nanotubes (Palomäki et al., 2014) have been published. However, there have been no
intracellular proteome studies, or secretome characterizations of human primary macrophages
upon exposure to danger signals. Some examples of proteomic studies with the emphasis on
secretome characterization from innate immune cells are listed in Table 4.
Table 4. Selected innate immune studies utilizing proteomics.
Stimulant Studied
fractions
Cell model Reference
R848 cell extract human
macrophages
(Rakkola et al., 2007)
chitosan, LPS secretome BMDCs (Villiers et al., 2009)
Staphylococcus aureus cell extract THP-1 cell line (Miller et al., 2011b)
influenza A virus secretome,
nucleus,
mitochondrion,
cytoplasm
human
macrophages
(Lietzén et al., 2011)
oxidized LDL cell extract BMDCs (Ge et al., 2011)
HSV-1 secretome human
macrophages
(Miettinen et al., 2012)
LPS+ATP, LPS+MDP secretome THP-1 cell line (Groessl et al., 2012)
LPS secretome BMDMs (Meissner et al., 2013)
Francisella tularensis membrane lipid
rafts
J774.2 cell line (Härtlova et al., 2014)
COX crystals cell extract U937 cell line (Singhto et al., 2013)
LPS secretome,
cell extract
RAW264.7 cell
line
(Eichelbaum and Krijgsveld,
2014)
1,3-β-glucan secretome human
macrophages
(Öhman et al., 2014)
carbon nanotubes secretome human
macrophages
(Palomäki et al., 2014)
Candida albicans cell extract human
macrophages
(Reales-Calderón et al.,
2014)
HIV-1 cell extract human (Haverland et al., 2014)
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macrophages
LPS, R848, Pam3Cys cell extract immortalized
murine
macrophages
(Sjoelund et al., 2014)
LPS, influenza A virus secretome RAW264.7,
A549 cell lines
(Checconi et al., 2015)
Mycobacterium
tuberculosis
ER THP-1 cell line (Saquib et al., 2015)
LPS et al. phagosomes MBDMs (Dill et al., 2015)
Abbreviations: BMDCs, murine bone marrow-derived dendritic cells; BMDMs, murine bone marrow-derived
macrophages; COX, calcium oxalate; ER, endoplasmic reticulum; HIV-1, Human immunodeficiency virus
type-1; HSV-1, Herpes simplex virus 1
Immune responses are dynamic processes involving changes in the composition of
intracellular proteomes and organelle-specific proteomes. They also induce alterations in post-
translational modifications of proteins and protein-protein interactions. All of these processes can
be studied using modern MS-based proteomic methods, which have become increasingly popular
in recent years for studying immune responses (Meissner and Mann, 2014).
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2. AIMS OF THE STUDY
Macrophages are the central effector cells in innate immune reactions, and their activation
elicits defense responses in the affected tissue. The aim of this investigation was to characterize the
responses of macrophages activated with endogenous danger signals and microbe-derived
molecules. The specific aims were:
1. To characterize the protein secretion from human macrophages exposed to endogenous
danger signals alone and in combination with microbe-derived signals (I, IV)
2. To study the inflammatory response of macrophages from healthy subjects with a history of
reactive arthritis (ReA) upon detection of microbe-derived signals (II)
3. To study the signaling pathways related to the inflammatory response of human
macrophages exposed to mycotoxin trichothecenes (III)
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3. MATERIALS AND METHODS
3.1 CELL CULTURE
3.1.1 Human primary macrophages and monocytes (I-IV)
The majority of experiments in this project were conducted with human primary monocyte-
derived macrophages. Monocytes were isolated from leukocyte-enriched buffy coats from healthy
blood donors acquired from the Finnish Red Cross as previously described (Pirhonen et al., 1999).
Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats using Ficoll-
Paque PLUS gradient centrifugation (GE Healthcare). PBMCs were allowed to attach onto plates
for  45  min  at  37  °C  under  5%  CO2. Subsequently, unattached cells were washed away and the
monocytes were then cultured for 6 days in Macrophage-SFM (Life Technologies) supplemented
with 10 ng/ml Granulocyte macrophage colony-stimulating factor (GM-CSF, Biosource
International, Inc.) and antibiotics. These macrophages were used in experiments (I, III, IV).
Macrophages differentiated with GM-CSF acquire a pro-inflammatory phenotype exhibiting the
Th1 type of response and they represent a suitable model for exploring early innate immune system
reactions (Akagawa et al., 2006; Lacey et al., 2012).
Alternatively, a blood sample of 100 ml was obtained from healthy volunteer subjects (II).
More detailed data from blood donors can be found in publication II. PBMCs from blood were
isolated with Ficoll-Paque PLUS gradient centrifugation (GE Healthcare). PBMCs were left to
adhere for 1h, after which monocyte-enriched adherent cells were used in the experiments. In the
macrophage differentiation procedure, monocytes were purified from PBMCs by immunomagnetic
negative selection using the Robosep instrument (Stemcell Technologies) and EasySep Human
Monocyte Enrichment Kit (Stemcell Technologies). Monocytes were then plated with Macrophage-
SFM supplemented with 10 ng/ml GM-CSF and antibiotics, and allowed to differentiate into
macrophages for 7 days at 37 °C under 5% CO2; these macrophages were used in the experiments
(II).
3.1.2 Murine bone marrow-derived macrophages (IV)
Murine bone marrow-derived macrophages (MBDMs) were differentiated from murine bone
marrow cells of strain C57BL/6 wild type mice (Scanbur) and P2X7 receptor knock-out (P2RX7-/-)
mice (with C57BL/6 background, the Jackson Laboratory). Briefly, mice were sacrificed and femur
bone shafts were flushed to collect bone marrow cells. The cells were washed once and red blood
cells were lysed with Red Blood Cell Lysis Buffer (Sigma). The remaining cells were washed again
and then plated in media containing 80% complete RPMI (supplemented with 10% FBS, 1%
glutamine, 1% HEPES, 0,05 mM β-mercaptoethanol, 1 mM sodium pyruvate, non-essential amino
acids, and antibiotics), and 20% L929-conditioned DMEM. The cells were left to differentiate for 7
days at 37 °C under 5% CO2 and the resulting macrophages were used in the experiments.
3.1.3 Cell lines (IV)
Human monocytic cell line THP-1 (ATCC, TIB-202) with origin of acute monocytic leukemia
was also used. Prior to the experiments, THP-1 cells were differentiated into macrophage-like cells
by  culturing  them  in  complete  RPMI  media  (see  above),  supplemented  with  1  µg/ml  LPS
(Invivogen)  and  1000  U/ml  IFN-γ (ImmunoTools)  for  48h  as  described  before  (Humphreys  and
Dubyak, 1998).
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3.2 REAGENTS AND CELL STIMULATIONS
 Human primary macrophages and monocytes, murine bone-marrow derived macrophages
and monocytic THP-1 cells were activated with multiple bacteria-, fungi- and virus-derived
molecules, as well as endogenous damage molecules. All of the stimuli used are listed in Table 5.
The  cells  were  stimulated  in  the  same  media  as  used  for  culturing  them  (Macrophage-SFM  for
human macrophages and monocytes, complete RPMI for murine bone-marrow derived
macrophages and THP-1 cells). Alternatively, if the secreted proteins were to be studied from the
cell culture media with mass spectrometry or Western blotting, the media was changed to RPMI
without serum before the stimulations. The details of the stimulations can be found in the
publications listed in the table.
Table 5. Pathogen-derived and endogenous molecules used in this study.
The cellular signaling pathways were manipulated with chemical and pharmacological
inhibitors, which are listed in Table 6. All of the inhibitors were added to the cells from 30 min to
1h before activation with the appropriate stimuli. When the activation of inflammasome was
studied, the cells were primed with LPS before treatment with the inhibitors. The details of
stimulations with inhibitors can be found in the publications listed in Table 6.
Stimulus Manufacturer Conc Time Publica
tion
Bacteria-derived molecules
LPS (Eschericia coli O111:B4) Sigma-Aldrich 100 ng/ml, 1
µg/ml
6h, 24h I, III, IV
LPS (Eschericia coli O55:B5) Sigma-Aldrich 10 ng/ml 18h II
Muramyl dipeptide (MDP) Sigma-Aldrich 100 ng/ml 18h II
Yersinia enterocolitica O:3 - 40 bact/cell,
100 bact/cell
18h II
Nigericin Sigma-Aldrich 10µM 2h IV
Endogenous molecules
Monosodium urate (MSU) Enzo Life
Sciences
100 µg/ml 3h, 6h I,II
ATP Sigma-Aldrich 3 mM, 5 mM 5-30min, 1-4h III, IV
Fungi-derived molecules
roridin A Sigma-Aldrich 10 ng/ml 4h III
verrucarin  A Sigma-Aldrich 10 ng/ml 4h III
1,3-β-glucan curdlan Sigma-Aldrich 30 µg/ml 18h IV
Virus-derived molecules
poly(dA:dT) Sigma-Aldrich 2 µg/ml 4h III
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Table 6. Chemical and pharmacological inhibitors of signaling pathways used in this study.
Inhibitor Target Manufacturer Conc Publica
tion
AZ11645373 P2X7 receptor Sigma-Aldrich 1 µM III
BAPTA-AM Ca2+ chelator Enzo Life
Sciences
10 µM IV
Ca-074 Me Cathepsin B Calbiochem 25 µM I
Calpeptin Calpain 1 and 2 Calbiochem 100 µM IV
diphenyleneiodonium
chloride (DPI)
NADPH oxidase,
nitric oxide
synthetase (NOS)
Sigma-Aldrich 1 µM III
KCl cell culture media
supplement
Sigma-Aldrich +1 mM
supplementation to
media
III
LY-294002 PI3 kinase Sigma-Aldrich 100 µM I
MDL28170 (Calpain
inhibitor III)
Calpain 1 and 2 Calbiochem 10-100 µM IV
N-acetyl-L-cysteine
(NAc)
reactive oxygen
species (ROS)
scavenger
Sigma-Aldrich 5 mM III
PD150606 Calpain 1 and 2 Calbiochem 100 µM IV
PF-431396 Pyk2 kinase Sigma-Aldrich 10 µM I
PP2 Src family kinases Sigma-Aldrich 5 µM, 10 µM I, III
Src inhibitor I Src family kinases Calbiochem 10 µM III
tyrphostin AG 126 tyrosine kinases Sigma-Aldrich 50 µM III
Z-YVAD-FMK
(Caspase-1 inhibitor VI)
Caspase-1 Calbiochem 25, 50 µM IV
The signaling pathways were also studied using RNA interference (RNAi) with small
interfering (si)RNA molecules as a way to obtain macrophages with reduced amounts of the target
proteins (III). siRNA treatment affects the abundance of the target protein by binding the mRNA
coding  for  the  protein,  and  by  inducing  its  degradation.  siRNA  treatment  of  the  primary
macrophages was conducted 24h before stimulations using pre-designed FlexiTube siRNAs
(Qiagen) against NLRP3 (Hs_CIAS1_6, Hs_CIAS1_9, Hs_CIAS1_10, Hs_CIAS1_11), P2X7
(Hs_P2RX7_1,Hs_P2RX7_2)  and  Cbl  (Hs_CBL_7,Hs_CBL_8).  The  protocol  for  siRNA
transfections is described elsewhere (Palomäki et al., 2011).
3.3 SAMPLE COLLECTION AND ANALYSES
After the stimulations, cells and cell culture supernatants were collected for analysis (see
below for details). Prior to the analysis of secreted proteins with proteomics and Western blotting,
supernatants were concentrated with Amicon Ultra-15 centrifugal filter devices (Merck Millipore)
to enable detection of proteins in a dilute solution.  All of the secreted proteins were concentrated
by  passage  through  filters  with  a  10  NMWL  (Nominal  molecular  weight  limit)  cut-off  (I,  IV).  In
order to separate the supernatant into vesicle-enriched and vesicle–free fractions, supernatants
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were first concentrated through 100 NMWL filters to obtain the vesicle-enriched fraction. Then,
material passing through the 100 MNWL filters was concentrated with 10 NMWL to obtain the
vesicle-free fraction (I, IV). In order to isolate secreted vesicles more accurately from the
supernatants, they were ultracentrifuged as described elsewhere (Cypryk et al., 2014) (IV).
3.3.1 2-D electrophoresis (I)
In the 2-D electrophoresis, proteins in concentrated supernatants were purified with a 2-D
Clean-Up kit (GE Healthcare). The purified proteins were resuspended in rehydration buffer (7M
urea, 2M thiourea, 4% CHAPS, 0.6% dithiothreitol, 0.5% IPG-buffer 3-10 (GE Healthcare), 0.004%
bromphenol  blue).  The samples  were then applied onto 11  cm immobilized pH gradient  pH 3-10
ReadyStrip IPG strips (Bio-Rad), which were left to rehydrate for 24h at room temperature.
Isoelectric focusing of proteins on the strip was performed with Ettan IPGphor II (GE Healthcare)
for a total of 63.3 kVh. Before the second dimension electrophoresis, the strips were equilibrated in
SDS-equilibration  buffer  (6M  urea,  30%  glycerol,  2%  SDS,  50mM  Tris-HCl  pH  8.8,  0.004%
bromphenol blue) supplemented with 10 mg/ml dithiothreitol for 15 min at room temperature,
followed by a similar equilibration in SDS-equilibration buffer supplemented with 25 mg/ml
iodoacetamide.  The  strips  were  loaded  onto  Criterion  10-20%  Tris-HCl  gels  (Bio-Rad)  and  SDS-
PAGE was run at 200V for 1h. Proteins were visualized after silver staining (O'Connell and Stults,
1997).
Image analyses of 2-DE gels were performed with ImageMaster 2D Platinum version 6.0 (GE
Healthcare, USA). Protein spots, whose intensities based on spot volumes, were statistically
significantly different (Student’s t-test, p<0.05, n=3) between sample groups were chosen to be
identified by mass spectrometry.
3.3.2 Mass spectrometry for protein identification (I, IV)
Separated and visualized protein spots were cut out from 2-DE gels for protein identification.
In the total protein identification from secretomes, the proteins were separated with SDS-PAGE,
and the gel was silver stained to visualize the proteins (O'Connell and Stults, 1997). Then the whole
lane was cut into fragments. In both cases, the proteins were in-gel digested with trypsin (Savijoki
et  al.,  2011).  The  resulting  peptides  were  analysed  with  Ultimate  3000  nano-LC  (Thermo  Fisher
Scientific Dionex) and a QSTAR Elite hybrid quadrupole time-of-flight mass spectrometer (AB
Sciex) with nano-ESI ionization as described in more detail in the original publication I. To identify
proteins from mass spectrometry data, the obtained LC-MS/MS spectra was searched with the
Mascot search engine through the ProteinPilot interface against SwissProt database.
3.3.3 Proteomics data analysis (I, IV)
The identified proteins were assigned to their Gene Ontology (GO) annotations (Ashburner et
al., 2000) using GoMiner (Zeeberg et al., 2003). The functional pathways among identified
proteins were further explored with GeneTrail (Backes et al.,  2007) (I) and DAVID (Huang et al.,
2008) (IV). The Interferome database was used in identifying known interferon (IFN) regulated
proteins (Samarajiwa et al., 2009) (I). Conventionally secreted proteins were identified with the
prediction tool SignalP 4.0, which recognizes proteins having a possible signal peptide (Petersen et
al., 2011) (I, IV). Unconventional exosomal secretion of proteins was analysed by comparing the
identified proteins with the ExoCarta database which consists of known exosomal proteins
(Mathivanan et al., 2012) (I, IV).
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3.3.4 Western blotting (I, III, IV)
Prior to the protein detection from whole cell lysates, cells were collected in total cell lysis
buffer  (10 mM Tris  pH 7.4,  150 mM NaCl,  25% ethylene glycol)  supplemented with Complement
Mini protease inhibitor (Roche Applied Science) and homogenized with ultrasound sonication. The
protein concentration of whole cell lysates was measured with DC Protein Assay (Bio-Rad).
In the detection of phosphorylated proteins from whole cell lysates, cells were collected in
buffer containing 50mM Hepes pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA supplemented with
protease inhibitor cocktail and phosphatase inhibitor cocktails 2 and 3 (Sigma-Aldrich). The cells
were lysed by incubation on ice for 1h. Then, the cell extract was centrifuged at 12000g for 30 min
to remove cell debris and supernatants was collected for protein detection (III).
In the protein detection from the subcellular fractions, the cells were fractionated with
QPreoteome Cell Compartment kit (Qiagen). The protein concentration of subcellular fractions was
measured with 2D Quant Kit (GE Healthcare) (IV).
In the detection of ASC from detergent soluble and insoluble cell fractions, the ASC
oligomerization assay was performed in principally as described before (Fernandes-Alnemri et al.,
2010; Zhao et al., 2014). After stimulation, cells were rinsed with ice-cold phosphate buffered
saline (PBS), collected in PBS and pelleted by centrifugation. The cell pellet was suspended in lysis
buffer  (20  mM  Hepes-KOH  pH  7.5,  150  mM  KCl,  1%  NP-40,  0.1  mM  PMSF,  protease  inhibitor
cocktail (Sigma-Aldrich)) and homogenized by shearing with a 23g needle and syringe. The
detergent insoluble fraction was pelleted by centrifugation at 5000g at 4°C for 10 min. The
supernatant was collected as the soluble fraction. The pellet was suspended in PBS and
oligomerized ASC was cross-linked with 2 mM disuccinimidyl suberate (DSS) for 30 min at 37°C,
after which the insoluble fraction was pelleted by centrifugation at 5000g at 4°C for 10 min and
suspended directly in SDS buffer (IV).
Equal amounts of proteins from cell lysates or representative volume of concentrated cell
culture supernatants were loaded on Mini-Protean TGX precast gels (Bio-Rad) for SDS-PAGE
followed by transfer to Immobilon-P Transfer Membranes (Merck Millipore). Incubation with
primary antibody against the protein of interest (Table 7.)  was  done  overnight  at  4°C.   The
samples were incubated with the appropriate HRP-conjugated secondary antibody (Dako) for 1 h at
room temperature. Proteins were visualized with ECL reagents and images were captured with
ImageQuant LAS 4000 mini CCD camera (GE Healthcare).
Table 7. Antibodies used in this study
Antibody against Manufacturer Publication
Annexin-1 Calbiochem I
Alix Santa Cruz Biotechnology IV
ASC Merck Millipore I, IV
Calpain-1 Santa Cruz Biotechnology IV
Calpain-2 Sigma-Aldrich IV
Caspase-1 Sigma-Aldrich IV
Caspase-3 Cell Signaling Technology I, IV (suppl)
Cathepsin B Calbiochem I
Cathepsin D Santa Cruz Biotechnology I
Cbl Santa Cruz Biotechnology III
GAPDH Santa Cruz Biotechnology IV
Galectin-3 Santa Cruz Biotechnology I, IV
IFIT-3 (RIG-G) BD Biosciences I
HSP90 Cell Signaling Technology I
IL-1β kindly provided by Prof. Ilkka Julkunen I
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IL-1β Cell signaling Technology IV
IL-18 Pirhonen et al., 1999 I
ITGAX (CD11c) Novus Biologicals IV
LAMP-1 Santa Cruz Biotechnology I, IV
MxA Ronni et al., 1993 I
P2X7 Santa Cruz Biotechnology III
Talin-1 Sigma-Aldrich IV
TSG101 Santa-Cruz Biotechnology IV
α/β-tubulin Cell Signaling Technology IV
phospho-Src Cell Signaling Technology III
3.3.5 Nanoparticle tracking analysis and electron microscopy of vesicles (IV)
Isolated extracellular vesicles were suspended in PBS and their abundance and size
distributions were analyzed with a nanoparticle tracking analysis (NTA) instrument LM14C
(NanoSite Technology) and CMOS camera (Hamamatsu Photonics K.K.). In the electron
microscopy (EM) imaging,  the  isolated vesicles  in  PBS were fixed with 1:1  4% paraformaldehyde,
and images were acquired with Jeol 1200 EX II transmission electron microscope. Both NTA and
EM of vesicles have been described previously in detail (Cypryk et al., 2014).
3.3.6 Enzyme-linked immunosorbent assay (ELISA) and luminex (I-IV)
The amount of IL-1β from cell culture supernatant was measured with human IL-1β Eli-pair
ELISA kit (Diaclone, Tepnel Research Products & Services) (I, III, IV), or with human IL-1β Ready-
Set-Go! kit (eBioscience) (II, IV). Secreted IL-18 from the cell culture supernatant was analyzed
with the human IL-18 module set (Bender MedSystems) (I). TNF was analyzed with TNF-α Ready-
Set-Go! kit (eBioscience) (II, III).
The amounts of CCL2, CCL3, CCL4, CCL5 and CXCL10 from cell culture supernatants were
analyzed with a Luminex instrument Bio-Plex 200 (BioRad) with Bio-Plex Manager 4.1.1 software
(BioRad) and custom-made Bio-Plex Pro Assay (BioRad) (I). IL-6, IL-12(p70) and IL-23 from cell
culture supernatants were analyzed using the same Luminex system as described above and
Milliplex kits for the analytes in question (Merck Millipore) (II).
3.3.7 Cytotoxicity assay, apoptosis assay and imaging of the cells (I, IV)
Cell cytotoxicity was assayed by measuring the activity of lactate dehydrogenase (LDH) from
cell culture supernatants with Cytotoxicity Detection Kit Plus (LDH) (Roche Applied Science)
(I,IV). For detection of apoptosis in the cultured cells, they were treated according to the
APOPercentageTM Apoptosis Assay (Biocolor Ltd). Captures of cells were taken with Olympus DP70
camera connected with Olympus IX71 inverted microscope (Olympus Corporation) (I). Images
from live cells were taken using EVOS FL fluorescent microscopy (Life technologies) using
transmitted light.
3.3.8 Calpain activity assay (IV)
Calpain activity from BMDMs was measured with the CalpainGLO Protease Assay (Promega)
with the protocol described before with minor modifications (Seyb et al., 2008). Briefly, BMDMs
were plated on white 96-well plate and allowed to attach overnight. Calpain substrate (20 µM) was
added to the cells, which were then incubated for 30 mins. Subsequently, the cells were stimulated
with 3 mM ATP for 30 min. Then media was removed and cells were lysed with 0.9% Triton-X, 50
µl per well. CalpainGLO luciferase detection reagent (1:1 to lyses buffer) was added to the wells and
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the plate was incubated for 15 min at RT with gentle shaking. The luminescence was read with a
Victor3 multilable plate reader (PerkinElmer).
3.3.9 Potassium (K+) efflux (IV)
The K+ content of the human primary macrophages was measured with Agilent 7500 ce/cx
ICP-MS. After stimulation of the cells,  the medium was removed and the cells were lysed in 70%
nitric acid (Romil-SpA) at RT overnight. On the next day the samples were diluted with 3.5% HNO3
and analyzed according to ISO 17294-2 in helium mode.
3.3.10 RNA extraction, cDNA synthesis and quantitative real-time PCR (I, III, IV)
Total cellular RNA was extracted from the cells with Eurozol and Euro-Gold RNA Pure
(EuroClone)  (I),  Trizol  reagent  (Life  Technologies)  (III),  or  with  RNeasy  Plus  Mini  Kit  (Qiagen)
(IV). RNA was reverse transcribed to cDNA with the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) (I, III, IV). In the gene expression analysis, cDNA was mixed with
PerfeCta qPCR FastMix (Quanta Biosciences) (I) or TaqMan Fast Universal PCR Master Mix
(Applied Biosystems) (III, IV), and predesigned TaqMan Gene Expression Assay primers and
probes. Quantitative real-time PCR was performed with ABI Prism 7500 Fast Real-time PCR
System (Applied Biosystems) controlled with 7500 Fast System SDS Software v1.4 (Applied
Biosystems). 18S rRNA was used as an endogenous control for each sample in the PCR
amplification to normalize the amount of cDNA between samples. The relative quantification of
gene expression of target genes was calculated using a comparative CT (also known as 2–ΔΔCT
method) method (Schmittgen and Livak, 2008).
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4. RESULTS
4.1 ACTIVATION OF HUMAN MACROPHAGES LEADS TO INDUCTION OF
UNCONVENTIONAL PROTEIN SECRETION (I,III,IV)
4.1.1 Stimulation of human macrophages with MSU or ATP leads to unconventional
protein secretion and release of extracellular vesicles (I,IV)
Macrophages are the main effector cells of innate immune responses. They communicate by
secreting proteins aimed at other cells. In this study, human primary macrophages were activated
with MSU (I) and extracellular ATP (IV), and secreted proteins were analyzed with quantitative 2-
DE (I) and/or qualitative LC-MS/MS following a protein separation by SDS-PAGE (Figure 7) (I,
IV). Activation of LPS-primed macrophages by MSU (100 µg/ml) for 3h, or unprimed macrophages
with ATP (3 mM) by 15 min induced robust protein secretion from the macrophages. There was no
sign of apoptosis or necrosis in the MSU-stimulated (I, supplemental Fig. S2) or ATP-stimulated
cells (IV, Fig. 5) at the time of sampling, and therefore it is concluded that secretion of proteins was
an active response of the macrophages to detection of MSU or ATP. These data show that innate
immune system activators MSU and ATP induce robust protein secretion from human
macrophages.
Figure 7. Workflow of proteomic experiments in manuscripts I and IV.
Proteins with an N-terminal signal peptide are secreted through the conventional secretion
pathway, and the secretion of other proteins, also called leaderless proteins, is said to follow the
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unconventional protein secretion pathway (Rabouille et al., 2012). A total of 68 proteins (of 372)
had a signal peptide in the secretome of LPS- and MSU-stimulated cells based on SignalP analysis
(I, Fig. 2). This demonstrates that the majority of the proteins secreted from MSU-stimulated cells
do not have a signal peptide and are secreted through unconventional secretion pathways.
Furthermore, when the proteins secreted from ATP-stimulated macrophages were analyzed, it was
found that 37 (of 188) had a signal peptide (IV, Fig. 1). Thus also ATP induces the unconventional
protein pathway type of secretion.
Unconventional secretion of proteins can be vesicle-mediated, channel-mediated or proteins
can be transported directly through the plasma membrane (Rabouille et al., 2012). Extracellular
vesicles like exosomes have been shown to take part in immune responses (Robbins and Morelli,
2014). The secreted proteins from LPS+MSU- and ATP-stimulated macrophages were compared to
the database ExoCarta which contains all known exosomal proteins. From LPS-primed MSU-
stimulated  cells,  292  (of  372)  proteins  were  found  in  ExoCarta  (I,  Fig.  2).  Furthermore,  109
proteins (of 172) identified from 2-DE that were more abundant in LPS-primed MSU-stimulated
cell secretome were found in ExoCarta. This reveals that the majority of proteins secreted from
MSU-stimulated cells were likely to have been secreted in exosomes or other extracellular vesicles.
Vesicle-mediated secretion upon MSU-stimulation was verified with leaderless proteins annexin-1,
galectin-3 and heat shock protein 90 (HSP90), as their abundances were increased in the vesicle-
enriched fraction of the supernatants (I, Fig. 3).
From ATP-stimulated cell secretome, 169 proteins (of 188) were found in ExoCarta (IV, Fig.
1) suggesting that there had been activation of vesicle-mediated unconventional protein secretion.
Secretion of four proteins previously encountered in exosomes based on ExoCarta, i.e. talin-1,
integrin alpha-X (ITGAX), α/β-tubulin and galectin-1 from ATP-stimulated cells was verified with
Western blotting (IV, Fig. 1). The extracellular vesicles in the cell culture media were isolated after
15 min of ATP exposure, and with electron microscopy (EM) it was possible to demonstrate the
abundance of vesicles in ATP-stimulated cell secretome (IV, Fig. 1). When isolated vesicles were
studied with nanoparticle tracking analysis (NTA), a 200-fold induction of vesicle secretion was
observed from ATP-stimulated cells compared to control cells (IV, Fig. 3). In summary, these data
indicate that MSU- and ATP-induced activation of macrophages initiates robust vesicle-mediated
unconventional protein secretion from cells.
4.1.2 MSU-induced unconventional protein secretion in macrophages is mediated by
cathepsins, and Src, Pyk2, and PI3 kinases (I)
Lysosomes are organelles that degrade molecules derived from the cell’s own components, or
from extracellular material taken up by the cell via phagocytosis. Cathepsins are an important
group of lysosomal proteases. These enzymes are present in pro-forms and mature forms, which
are the biologically active proteases (Turk et al., 2012). When the proteins secreted from human
macrophages were analyzed, it was observed that cathepsins D, S and Z were more abundant in
LPS-primed MSU-stimulated cell secretomes compared to LPS-primed secretomes (I,
supplemental Table S2). Cathepsin B and pro-cathepsin H were also identified from the MSU-
stimulated cell secretome. The secretions of cathepsins B and D were analyzed with western
blotting and it could be demonstrated that mature forms of cathepsins B and D were being secreted
after MSU-stimulation of macrophages (I, Fig. 4). Treatment with a cathepsin-specific inhibitor Ca-
074  Me  (25  µM)  was  used  to  explore  the  role  of  cathepsins  in  protein  secretion  after  MSU
stimulation. Protein secretion upon MSU stimulation was clearly reduced if the cells were treated
with Ca-074 Me as assessed by silver staining the secreted proteins (I, Fig. 4). This was verified by
analyzing the secretion of three proteins i.e.  interferon-induced protein with tetratricopeptide
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repeats 3 (IFIT-3), galectin-3, and lysosome associated membrane glycoprotein-1 (LAMP-1) from
the MSU-stimulated cell secretome. Their secretion was reduced if the cells were treated with
cathepsin-specific inhibitor Ca-074 Me before the MSU-stimulation (I, Fig. 4). The secretion of
unconventionally secreted cytokines IL-1β and IL-18, and NLRP3 inflammasome adaptor protein
ASC was also analyzed from LPS-primed cells upon MSU stimulation after the cells had been
treated with Ca-074 Me. The secretion of ASC declined, and the secretion of biologically active
forms of IL-1β and IL-18 was completely blocked from Ca-074 Me treated cells. Importantly,
treatment of cells with Ca-074 Me did not have any effect on MSU-induced secretion of the
conventionally secreted chemokines i.e. CCL2, CCL3 and CCL4 from LPS-primed cells, indicating
that cathepsin activity is essential only in MSU-induced unconventional protein secretion (I, Fig.
4).
The activity of proteins in signaling pathways is commonly regulated by phosphorylation
(Lowell, 2011). Proteins related to phosphorylation including Src family kinases proto-oncogene
tyrosine-protein kinase Src and tyrosine-protein kinase Lyn were identified in the MSU-stimulated
cell secretome (I, supplemental Table S3), and thus it was decided to analyze the role of Src family
kinases in MSU-induced protein secretion. By treating the cells with the Src family kinase inhibitor
PP2 (10 µM), MSU-induced overall protein secretion was completely inhibited as assessed by silver
staining of secreted proteins (I,  Fig. 5). Src family of proteins is involved in the integrin signaling
cascade with kinases tyrosine kinase 2-β (Pyk2) and phosphatidyl-inositol 3-kinase (PI3K) (Fuortes
et al., 1999). Therefore the cells were treated with the Pyk2 inhibitor PF-431396 (10 µM) and PI3K
inhibitor LY-294002 (100 µM), and it was demonstrated that they also inhibited MSU-induced
protein secretion completely (I, Fig. 5). Furthermore, the MSU-induced secretion of IL-1β, and
mature forms of cathepsins B and D from LPS-primed cells was blocked after treatment with PP2,
PF-431396 and LY-294002 (I, Fig. 5) indicating that signaling through Src family kinases, Pyk2
and PI3K is essential in MSU-induced unconventional protein secretion.
4.1.3 ATP-induced protein secretion from macrophages is dependent on calpain
activity (IV)
The  enriched  GO  terms  and  biological  pathways  among  proteins  secreted  only  from  ATP-
stimulated macrophages were analyzed. GO terms and pathways associated with cell motion,
adhesion and signaling related to calpains were found to be enriched (IV, Fig. 2). Calpains are Ca2+-
activated cytosolic proteases, and their substrates are usually cytoskeletal proteins. They are
believed to be translocated from cytoplasm to membranes after cell activation (Goll et al., 2003). It
was found that when cells were stimulated with ATP (3 mM) for 30 min, the abundance of calpains
1 and 2 increased in both the cytosol and membrane fractions (IV, Fig 2). It was decided to measure
their activity upon ATP stimulation in wild type (WT) and P2X7-deficient (P2RX7-/-) mouse
macrophages. ATP stimulation increased calpain activity in WT cells, but not in P2RX7 -/- cells
which is evidence that ATP-induced activation of calpains is P2X7-dependent (IV, Fig. 2).
Next, the cells were treated with the calpain inhibitor MDL28170 (100 µM) and then
stimulated with ATP for 15 min prior to analysis of protein secretion by blotting four exosomal
proteins, i.e. talin-1, ITGAX, α/β-tubulin, and galectin-3 from the supernatants of MDL28170-
treated ATP-stimulated macrophages (IV, Fig. 3). The analysis showed that protein secretion from
MDL2810-treated cells was completely prevented upon ATP-stimulation. The secreted
extracellular vesicles were isolated from secretomes of untreated and MDL28170-treated cells upon
ATP exposure; it was found that ATP-induced vesicle secretion was totally dependent on calpain
activity (IV, Fig. 3).
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ATP is an activator of NLRP3 inflammasome, and promotes caspase-1-dependent secretion
of  cytokine  IL-1β (Mariathasan  et  al.,  2006).  The  effect  of  calpain  inhibitor  MDL28170  on  the
secretion of cytokine IL-1β was analyzed from the macrophages. ATP stimulation alone did not
activate the secretion of IL-1β since the transcription of pro-IL-1β is not constitutively active, and
ATP  is  unable  to  activate  it.  The  cells  were  primed  with  LPS  (1  µg/ml)  to  induce  pro-IL-1β
production before stimulation with ATP. The secretion of IL-1β was dose-dependently decreased as
the  MDL28170  concentration  increased  (IV,  Fig.  4).  It  was  also  verified  that  MDL28170  did  not
affect the transcription of pro-IL-1β or NLRP3 (IV, supplemental Fig. S1), or protein levels of pro-
IL-1β (IV, Fig. 4). Other calpain inhibitors i.e. calpeptin (100 µM) and PD150606 (100 µM), were
also used to block calpain activity in LPS-primed cells after ATP-stimulation, and the amount of IL-
1β secreted was measured. Also in these experiments, IL-1β secretion was inhibited (IV, Fig. 4).
Since calpains are activated when Ca2+ concentration in the cells becomes elevated, it was decided
to treat the LPS-primed cells with the calcium chelator BAPTA-AM (10 µM) prior to ATP
stimulation. BAPTA-AM-treatment also blocked IL-1β secretion from macrophages (IV, Fig. 4).
This together with overall protein secretion data indicate that calpain activity is required for
unconventional protein secretion from ATP-activated macrophages.
Nigericin is a bacterial toxin, and a well-known activator of NLRP3 inflammasome and
inducer of secretion of IL-1β (Mariathasan et al., 2006). The 1,3-β-glucan, curdlan, is a fungal cell
wall constituent that is also activator of NLRP3 inflammasome and promoter of IL-1β secretion.
The 1,3-β-glucan, curdlan, provides also the priming signal needed for transcription of pro-IL-1β
(Kankkunen et al., 2010). It was decided to examine the requirement of calpain activity on IL-1β
secretion by nigericin or curdlan. The cells were primed with LPS for 4h, then treated with
MDL28170 and stimulated with nigericin (10 µM) for 2h. Alternatively, the cells were treated with
MDL28170 and stimulated with curdlan (30 µg/ml) for 18h. Interestingly, MDL28170 had different
effects  on  the  secretion  of  IL-1β evoked  after  stimulation  by  either  nigericin  or  curdlan.  From
curdlan-stimulated cells, the secretion of IL-1β was inhibited after treatment with MDL28170 (IV,
Fig. 4). In contrast, IL-1β secretion from nigericin-stimulated cells was increased after treatment
with  MDL28170  (IV,  Fig.  4).  To  conclude,  the  signaling  leading  to  secretion  of  IL-1β is  calpain-
mediated in 1,3-β-glucan-stimulated macrophages. However, from cells stimulated with nigericin,
the secretion of IL-1β is calpain-independent.
Caspase-1 has been proposed to regulate unconventional protein secretion (Keller et al.,
2008). Since during ATP stimulation, caspase-1 is activated in macrophages it was decided to
explore if above vesicle-mediated unconventional secretion was dependent on caspase-1 activity.
Macrophages were treated with the caspase-1 specific inhibitor Z-YVAD-FMK (25 µM) before ATP
activation. Interestingly, blockade of caspase-1 did not have any effect on overall protein secretion
from cells (IV, Fig. 7). This was also verified by analyzing the secretion of four exosome-associated
proteins i.e. talin-1, ITGAX, α/β-tubulin, and galectin-3 by western blotting of secretomes from Z-
YVAD-FMK-treated cells exposed to ATP (IV, Fig. 7). These data indicate that even though
secretion of IL-1β is mediated by activated caspase-1 from ATP-stimulated macrophages, it does
not regulate their vesicle-mediated protein secretion.
4.1.5 Trichothecene mycotoxin roridin A activates the secretion of IL-1β and IL-18
via NLRP3 inflammasome (III)
Trichothecene mycotoxins are produced by several species of fungi, including Stachybotrys
chartarum, which has been suggested to be involved in damp-buildings associated illnesses
(Pestka  et  al.,  2008).  Three  trichothecene  mycotoxins  i.e.  roridin  A,  verrucarin  A  and  T-2  toxin,
have previously been shown to activate the caspase-1-dependent secretion of cytokines IL-1β and
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IL-18 from human macrophages (Kankkunen et al., 2009). In this study, RNA interference was
utilized  to  explore  the  involvement  of  NLRP3  inflammasome  in  the  secretion  of  IL-1β and  IL-18
after roridin A exposure. Macrophages were treated with small interfering RNA (siRNA) against
NLRP3  proteins  for  24h  and  subsequently  the  cells  were  primed  with  LPS  (1  µg/ml)  for  2h,  and
stimulated with roridin A (1 µg/ml) for 4 hours. From cells treated with siRNA against NLRP3, the
secretions of IL-1β and IL-18 were significantly lower than from cells treated with control siRNA
(III, Fig. 1).  The siRNA treatment did not have any effect on the transcription levels of IL-1β and
IL-18. It is concluded that roridin A-induced secretion of IL-1β and IL-18 is mediated through
activation of the NLRP3 inflammasome.
4.2 INFLAMMASOME ACTIVATION IN HUMAN MACROPHAGES (III, IV)
4.2.1 Activation of NLRP3 inflammasome by roridin A is mediated by ROS
production, K+ efflux, and cathepsins (III)
The mechanism of NLRP3 inflammasome activation after roridin A was explored. The
production of reactive oxygen species (ROS), potassium (K+) efflux and cathepsin release from
lysosomes have been associated with NLRP3 inflammasome activation by multiple stimuli
(Tschopp, 2011). Here, human macrophages were treated with the common ROS scavenger, N-
acetyl-L-cysteine (NAc, 5 µM), or an inhibitor of NADPH oxidase, diphenylene iodonium chloride
(DPI,  1  µM),  before  treatment  with roridin A.  Both NAc and DPI inhibited the secretion of  IL-1β
and IL-18 from LPS-primed macrophages in response to roridin A stimulation (III, Fig. 2).
K+ efflux has been postulated to be a prerequisite of NLRP3 inflammasome activators in all
known stimuli (Muñoz-Planillo et al., 2013). Human macrophages were stimulated with roridin A
in the presence in the cell culture media of additional potassium chloride to prevent K+ efflux. LPS-
primed macrophages stimulated with roridin A in the presence of additional potassium chloride
displayed a marked reduction in their secretion of IL-1β and IL-18 in comparison to macrophages
stimulated without additional potassium chloride in the media (III, Fig. 2).
Lysosomal rupture leading to cathepsin leakage to cytosol has been shown to activate the
NLRP3 inflammasome by particular agonists, like silica crystals or aluminium salts (Hornung et
al.,  2008).  Here,  the  cathepsin  specific  inhibitor,  CA-074  Me  (25  µM),  was  used  to  block  the
activity of the cathepsins after roridin A treatment. The secretion of IL-1β and IL-18 were
significantly reduced from CA-074 Me –treated LPS-primed macrophages activated with roridin A
(III, Fig. 2). These data together show that ROS formation, K+ efflux and the activity of cathepsins
are all needed in roridin A-induced NLRP3 inflammasome activation. In addition, the priming
effect evoked by LPS activating the transcription of pro-IL-1β and IL-18 was unaffected by the ROS
inhibitors, potassium chloride supplementation of the media and Ca-074 Me. This confirms that
the inhibitory  effects  evoked by the blockade of  ROS formation,  K+ efflux and the cathepsins are
targeting the NLRP3 inflammasome activation, and/or the secretion phase of IL-1β and IL-18.
4.2.2 NLRP3 inflammasome activation by roridin A is mediated by the P2X7
receptor, and Src tyrosine kinases (III)
Activation of P2X7 receptor mediates the NLRP3 inflammasome activation on extracellular
ATP  (Mariathasan  et  al.,  2006).  It  was  decided  to  explore  the  involvement  of  P2X7  receptor  in
macrophage signaling activated by roridin A by exploiting the P2X7 receptor’s pharmacological
inhibitor, AZ11645373 (1 µM). Roridin A –induced secretion of IL-1β from LPS-primed
macrophages was inhibited by AZ11645373-treatment (III, Fig. 3). To verify this result, the
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macrophages were treated with the siRNA against P2X7 for 24h before LPS-priming and activation
by roridin A. This treatment reduced the secretion of IL-1β compared to that from cells treated with
control siRNA (III, Fig. 3). This demonstrates that roridin A –induced signaling in macrophages
leading to NLRP3 inflammasome activation is at least partly mediated by the P2X7 receptor.
It  has  been shown previously  that  ATP-induced processing of  IL-1β can be inhibited by the
tyrosine kinase inhibitor, tyrphostin AG126 (Kahlenberg and Dubyak, 2004). In the current study,
the effect of AG126 was studied on roridin A-induced secretion of IL-1β and IL-18. It was observed
that the secretion of IL-1β and IL-18 from LPS-primed macrophages was inhibited after roridin A-
stimulation if the cells had been treated with AG126 (50 µM) (III, Fig. 4). This demonstrates that
tyrosine kinase signaling is needed for the NLRP3 inflammasome activation occurring in response
to roridin A stimulation.
Next, the involvement of Src family tyrosine kinases was studied in roridin A-induced
signaling in macrophages by treating the LPS-primed cells with the Src family kinase inhibitor PP2
(5  µM)  before  stimulation  with  roridin  A.  The  secretion  of  IL-1β and  IL-18  from  macrophages
treated with PP2 was blocked after roridin A activation (III, Fig. 4). This was also verified with
another  Src  family  kinase  inhibitor,  Src  inhibitor  I  (10  µM),  which  gave  similar  results  (III,
supplemental Fig. 1).  In addition, PP2 was used with another trichothecene mycotoxin, verrucarin
A, and it was found that IL-1β secretion was blocked from LPS-primed PP2-treated macrophages
activated with verrucarin A (III, Fig. 4). Importantly, Western blotting also detected the
phosphorylated form of Src kinase emerging in the macrophages after 1h of roridin A –stimulation
(III, Fig. 4). In summary, this data demonstrates that Src family kinases become phosphorylated
after trichothecene exposure, and their activity is needed to mediate trichothecene –induced
NLRP3 inflammasome activation and secretion of IL-1β and IL-18.
The AIM2 inflammasome is another caspase-1 activating inflammasome complex, and it is
activated by the presence of cytoplasmic double-stranded DNA (Fernandes-Alnemri et al., 2009;
Hornung et al., 2009). It was decided to explore whether the Src family kinase signaling would be a
common requirement of inflammasome activation by priming macrophages with LPS (1 µg/ml) for
2h, treating them with PP2 (5 µM) and activating the AIM2 inflammasome with transfection of
poly(dA:dT) (2 µg/ml), a synthetic double-stranded DNA for 4h. It was possible to demonstrate
that PP2 treatment of cells completely blocked the activation of the AIM2 inflammasome (III, Fig.
4). c-CBL is a E3 ubiquitin ligase that ubiquitinates Src and mediates its degradation by autophagy,
a  process  for  recycling  the  cell’s  own  components  (Yokouchi  et  al.,  2001).  Here,  the  effect  of  Src
degradation on NLRP3 inflammasome activation was explored by treating the macrophages with
the siRNA against c-CBL for 24h and then priming them with LPS and activating with roridin A.
Interestingly, the secretion of IL-1β and IL-18 was markedly increased from cells treated with the
siRNA against c-CBL compared to cells treated with control siRNA (III, Fig. 5). This data reveals
that signaling through Src family kinases is needed to achieve AIM2 and NLRP3 inflammasome
activation. Furthermore, it indicates that the activation of NLRP3 inflammasome is regulated by
targeted degradation of Src kinase.
4.2.3 Inhibition of calpain activity blocks K+ efflux and activation of NLRP3
inflammasome by ATP (IV)
Calpains are Ca2+ -activated cytosolic proteases, and it was found that their activity is needed
in ATP-induced protein secretion, including the secretion of IL-1β if the cells had been primed with
LPS before ATP stimulation. To explore further the mechanisms of inhibited secretion of IL-1β, the
requirement of calpain in the activation of NLRP3 inflammasome was examined. Upon NLRP3
inflammasome activation, adaptor protein ASC oligomerizes to produce distinct specks inside the
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cells (Bryan et al., 2009). It was examined whether ASC oligomers could be detected in MDL28170-
treated  cells  by  priming  the  macrophages  with  LPS  (1  µg/ml)  for  6h,  then  treating  them  with
calpain inhibitor MDL28170 (100 µM) or leaving them untreated, and stimulating them with ATP
(3 mM) for 30 min. Then, the cells were collected, ASC oligomers cross-linked and analyzed by
western  blotting.  The  dimers  and  oligomers  of  ASC  were  readily  visible  in  the  LPS-primed  ATP-
stimulated cells (IV, Fig. 6). However, if the cells were treated with MDL28170, dimers and
oligomers of ASC were absent, and an ASC aggregate between 50-75kDa was clearly visible. This
indicates that the ASC oligomer formation is not normal in MDL28170-treated cells, and thus
NLRP3 inflammasome activation is prevented if the activity of the calpains is blocked.
 The secretion of inflammasome components upon NLRP3 inflammasome activation has
been detected in many studies (Martinon et al., 2006; Hornung et al., 2008; Muñoz-Planillo et al.,
2013). Macrophages were either unprimed, or primed with LPS for 6h, and then treated with the
MDL28170, and activated with ATP for 30 min. Then the secretion of components of the NLRP3
inflammasome was analyzed from the cell culture supernatants by western blotting. It was found
that ATP induced the secretion of ASC and the biologically active form of caspase-1 (p20) from
primed and unprimed cells, and MDL28170 completely inhibited their secretion upon ATP
stimulation (IV, Fig. 6). Moreover, the secretion of calpains 1 and 2 was detected from primed and
unprimed ATP-stimulated cells, and also their release was prevented by MDL28170 treatment (IV,
Fig.  6).  The  effect  of  MDL28170  on  the  secretion  of  inflammasome  components  from  the
monocytic cell line THP-1 after ATP stimulation was also explored; similar results were obtained
(IV, supplemental Fig. S2).
To  date,  K+ efflux  has  been  shown  to  be  the  common  denominator  for  all  known  NLRP3
inflammasome activators, including ATP (Muñoz-Planillo et al., 2013). To clarify the mechanisms
behind the inhibitory effect of MDL28170 on NLRP3 inflammasome activation K+ efflux was
measured from the macrophages. The cells were primed with LPS for 6h or left unprimed and then
treated with MDL28170 and stimulated with ATP for 30 min. Subsequently, the cells were lysed in
nitric acid, and K+ content of the cells was measured with ICP-MS.  MDL28170 treatment
completely inhibited the K+ efflux from ATP-stimulated cells (IV, Fig. 6). This demonstrates that
inhibition of calpain activity prevents the activation of NLRP3 inflammasome from ATP-stimulated
cells via K+ efflux dependent mechanism.
4.3 MACROPHAGES AS PROMOTERS OF THE INFLAMMATORY RESPONSE (I, II, IV)
4.3.1 Co-stimulation of macrophages with LPS and MSU induces a strong
inflammatory burst from macrophages (I)
The secretome of human macrophages was analyzed when the macrophages were primed
with LPS (100 ng/ml) for 21h and stimulated with MSU (100 µg/ml) for 3h. The secretome of LPS-
primed and LPS-primed MSU-stimulated cells contained a number of intracellular danger signal
proteins, or DAMPs, including annexins, galectins, heat shock proteins (HSPs) and S100 proteins
(I, Table 1). Some of these proteins like annexin A5, annexin A11, galectin-1, galectin-7, protein
S100 A4, and protein S100 A5 were more abundant in MSU-stimulated cell secretomes as
quantified by 2-DE. Furthermore, many DAMPs were present only in MSU-stimulated cell
secretomes including annexin A4, annexin A6, HSP 105 kDa, and HSP60. This indicates that MSU-
stimulation together with LPS-priming is able to produce the secretion of danger signals from
macrophages.
Cytokines and chemokines are signaling proteins that macrophages secrete to their
surrounding cells. These compounds induce inflammation and recruit other cells to the site of
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infection. It was possible to identify multiple cytokines and chemokines secreted from LPS-primed
MSU-stimulated cells. IL-18 and a range of chemokines (CCL5, CCL22, CCL24, CXCL1, CXCL3,
CXCL4,  CXCL7,  CXCL10  and  MIF)  were  identified  only  from  LPS-primed  MSU-stimulated  cell
secretome  (I,  Table  1).  The  secretion  of  chemokines  on  MSU  stimulation  was  further  verified  by
performing a luminex analysis of CCL2, CCL3, CCL4, CCL5, and CXCL10. The results clearly
indicated that MSU stimulation or LPS-priming alone did not induce the secretion of these
chemokines very efficiently (I, Fig. 3). However, LPS-priming together with MSU stimulation
resulted in efficient secretion of these chemokines. It was decided next to analyze the transcription
of these chemokines. The results showed that LPS-priming alone was sufficient for the activation of
gene expression of these chemokines, and MSU had only a modest effect on this property (I, Fig. 3).
This data indicates that LPS-priming turns on the transcription of chemokine expression in the
macrophages, but only after the detection of MSU is their secretion efficiently activated.
Another group of proteins identified in the LPS-primed MSU-stimulated cell secretome was
the interferon-induced proteins. Interferons (IFNs) are signaling molecules secreted by cells during
microbial infection, and their production induces the expression of many other proteins,
commonly referred to as interferon-induced proteins, which are involved in defense responses. The
secretome obtained here was compared to data contained in the Interferome database, which
collects genes and proteins known to be IFN-regulated from public databases (Samarajiwa et al.,
2009). Strikingly, more than 200 proteins from LPS-primed MSU-stimulated cell secretome were
found in Interferome. It was decided to apply a strict threshold, and analyze only those proteins
that  had  been  found  to  be  regulated  by  type  I  IFN  in  at  least  five  individual  studies  previously.
From LPS-primed MSU-stimulated cell secretome, 21 proteins belonged to this group, including
interferon-induced GTP-binding proteins Mx1 and Mx2 (MxA and MxB), interferon-induced
proteins with tetratricopeptide repeats 1, 2 and 3 (IFIT1, IFIT2, IFIT3), interferon-induced
guanylate-binding proteins 1 and 2 (GBP1 and GBP2), interferon-induced 17kDa protein (ISG15),
and interferon-induced 35kDa protein (IFI35) (I, Table 1). Subsequently, a Western blot analysis of
MxA and IFIT3 was performed from cell lysates and secretomes of macrophages and this indicated
that LPS-priming had induced the production of MxA and IFIT3 in the cell, but exposure to MSU
activated their secretion from the cells (I, Fig. 3).
To conclude, LPS stimulation activates the production of proteins related to inflammation
and defense responses in the cells. However, MSU stimulation induces their effective secretion
from  the  macrophages.  Thus  macrophages  exposed  to  LPS  and  MSU  together  produce  a  strong
inflammatory burst leading to the activation of other cells and defense responses.
4.3.2 ATP stimulation induces the secretion of danger signal proteins from
macrophages (IV)
Human macrophages were exposed to extracellular ATP (3 mM) for 15 min, and the proteins
they secreted were analyzed. Cells stimulated with ATP were discovered to secrete a range of
danger signal proteins (Table 8.). It is known that macrophage colony-stimulating factor 1 (M-
CSF) promotes the differentiation and survival of macrophages, which have alternative or M2-type
characteristics (Lacey et al., 2012). Interestingly, M-CSF was secreted from macrophages
stimulated with ATP, whereas it was not detected from the control secretome (IV, Supplemental
Table S1). These data indicate that detection of endogenous danger signal in the absence of a
microbe-derived signal rapidly induces the secretion of danger signal proteins from cells, and
possibly promotes the tissue regeneration by promoting the anti-inflammatory macrophages.
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Table 8. Danger signal proteins secreted from human macrophages
Uniprot
accession
Protein ctr ATP
P09525 Annexin A4 n.d. +
P50995 Annexin A11 n.d. +
P04083 Annexin A1 n.d. +
P26447 Protein S100-A4 n.d. +
P09382 Galectin-1 n.d. +
P17931 Galectin-3 n.d. +
P17066 Heat shock 70 kDa protein 6 n.d. +
P34932 Heat shock 70 kDa protein 4 n.d. +
Q92598 Heat shock protein 105 kDa n.d. +
P08107 Heat shock 70 kDa protein 1A/1B n.d. +
P11021 78 kDa glucose-regulated protein n.d. +
P07900 Heat shock protein HSP 90-alpha + +
P08238 Heat shock protein HSP 90-beta + +
P11142 Heat shock cognate 71 kDa protein + +
P05109 Protein S100-A8 + +
P06703 Protein S100-A6 + +
P07355 Annexin A2 + +
P08758 Annexin A5 + +
Abbreviations: n.d., not detected
4.3.3 Macrophages from subjects with a history of reactive arthritis show normal
secretion of IL-1β, but decreased secretion of TNF and IL-23 (II)
Reactive arthritis (ReA) is a sterile inflammatory joint disease that develops in response to
infection in the gut or urogenital track, caused by Gram-negative bacteria like Yersinia
enterocolitica. The pathogenesis of reactive arthritis is not known, but it may involve disturbances
in the innate immune response. This study was intended to explore the activation of inflammasome
in macrophages and peripheral blood-derived mononuclear cells (PBMCs) including monocytes,
from HLA-B27-positive healthy subjects with a history of reactive arthritis (n=10). The control
groups  were  cells  from  healthy  HLA-B27  positive  (n=10)  and  negative  subjects  (n=10).  The  cells
were activated with LPS (10 ng/ml), MDP (100 ng/ml), LPS together with MDP or Y. enterocolitica
O:3 (40 bacteria/cell for PBMC; 100 bacteria/cell for macrophages) for 18h. PBMCs were also left
untreated or activated with LPS (10 ng/ml for 15h) and then treated with MSU for 3h (100 µg/ml).
Then, the cell culture media was collected and secreted IL-1β was analyzed. The secretion of IL-1β
was comparable between the study groups with all used stimuli from both cell types (II, Table 1).
This indicates that the inflammasome activation is similar in cells of subjects who had previously
suffered from reactive arthritis compared to cells of healthy control subjects.
In order to verify that the method was able to detect abnormal inflammasome activation,
PBMCs and macrophages were obtained from patients with Muckle-Wells syndrome (MWS, n=1)
and familial cold-induced auto-inflammatory syndrome (FCAS, n=1). MWS and FCAS are both
auto-inflammatory disorders caused by mutation in NLRP3 protein promoting spontaneous and
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abnormally high activation of NLRP3 inflammasome (Agostini et al., 2004). The PBMCs and
macrophages were stimulated from patients and from healthy subjects with the stimuli listed
above. From patient PBMCs, the secretion of IL-1β was higher than from control cells with LPS,
MDP, LPS together with MDP, and LPS together with MSU (II, Table 1).  From macrophages, the
secretion of IL-1β from patient cells was considerably higher than that from control cells with all
stimuli tested (II, Table 1). This indicates that the method being used was able to detect abnormal
inflammasome activation, especially in macrophages.
The secretion of cytokines IL-12, IL-6, TNF and IL-23 was also analyzed from macrophages
of subjects with a history of ReA. The secretion of IL-12 was similar between study groups (II, Table
2).  In addition, the secretion of IL-6 was similar in the study groups, although there was an
increasing trend of IL-6 secretion activated by Yersinia where ReA-group < HLA-B27-positive
controls < HLA-B27-negative controls that was almost significant (p=0.062) (II, Table 2). In
support of this trend, the secretion of TNF from macrophages stimulated with LPS together with
MDP, and with Yersinia was significantly different between study groups. There was an increasing
trend towards TNF secretion where ReA-group < HLA-B27-positive controls < HLA-B27-negative
controls with LPS+MDP stimulation (p=0.027) and Yersinia (p=0.036) (II, Table 2). Furthermore,
the secretion of IL-23 was significantly different between the study groups. On Yersinia
stimulation, there was an increasing trend of IL-23 secretion where ReA-group < HLA-B27-
positive controls < HLA-B27-negative controls (p=0.026) (II, Table 2). To conclude, the production
of TNF and IL-23, and possibly IL-6 is less efficient from macrophages taken from subjects with a
history of reactive arthritis, than from macrophages of healthy controls when macrophages
encounter inflammation-promoting stimuli.
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5. DISCUSSION
The innate immune system responds rapidly to changes in the cellular environment caused
by  pathogens  or  tissue  damage.  The  main  effector  cells  of  the  early  phase  of  the  innate  immune
response i.e. macrophages and dendritic cells, detect the presence of molecules derived from
pathogens or ruptured cells by their pattern recognition receptors (PRRs). This activates and
evokes extensive alterations in the cells. For instance, macrophages increase their production of
ROS and NO, which are agents intended to kill ingested pathogens, and their surface molecules
also change. The cells start to express co-stimulatory molecules enabling them to undergo
interactions with lymphocytes. Additionally, macrophages and dendritic cells start to secrete a
battery of proteins including cytokines, chemokines and proteins promoting tissue repair.
Cytokines are signaling molecules eliciting an inflammatory response, and chemokines recruit
other immune cells to site of damage. The secretory responses emitted by activated macrophages
and dendritic cells upon detection of various stimuli have not been characterized in detail, and
there are still many unknowns in the signaling pathways utilized upon PRR activation.
5.1 PROTEIN SECRETION FROM MACROPHAGES
Endogenous molecules present in incorrect compartments or in excess amounts indicating
that the structure of the cells is compromised are potent activators of the innate immune system.
MSU and ATP are both such endogenous danger molecules, and well-known activators of the
innate immune system which are able to evoke an inflammation response through NLRP3
inflammasome activation and IL-1β secretion (Laliberte et al., 1999; Shi et al., 2003; Mariathasan
et  al.,  2006;  Martinon  et  al.,  2006).  Uric  acid  is  a  product  of  purine  metabolism,  and  when  its
concentration exceeds its solubility due to cell rupture or abnormalities in metabolism, it
crystallizes into MSU. ATP is the intracellular conveyor of chemical energy that is released from
damaged cells into the extracellular environment. This study characterized the effects MSU and
ATP exerted on secretory responses of human primary macrophages.
The cells were primed with Gram-negative bacteria-derived molecule LPS before activation
with MSU to explore the effects of co-stimulation with microbial-derived and danger signal. LPS is
a well-known activator of innate immune responses. Moreover, Meissner and co-workers have
demonstrated that LPS activates protein secretion from the mouse macrophages, but exposure of
eight hours or longer is necessary. (Meissner et al., 2013). In the present experimental settings with
human macrophages, LPS alone did not induce any remarkable protein secretion. In contrast,
three hours of MSU stimulation of the LPS-primed cells activated the protein secretion. It was also
observed that MSU induced a robust protein secretion from human macrophages that were
unprimed.  In line  with this,  when the unprimed human macrophages  were stimulated with ATP,
robust protein secretion was detected from these cells within 15 min. Protein secretion from the
activated human macrophages has also been detected in other studies. Human macrophages
stimulated with influenza A (Lietzén et  al.,  2011),  herpes  simplex virus  1  (Miettinen et  al.,  2012),
1,3-β-glucans (Cypryk et al., 2014; Öhman et al., 2014) and carbon nanotubes (Palomäki et al.,
2014) also activated protein secretion. This demonstrates that robust protein secretion is a
common response from activated human macrophages. Notably, ATP alone did not induce protein
secretion from unprimed murine macrophages (unpublished observation), which highlights the
differences that murine and human macrophages might have in their signaling cascades related to
protein secretion.
Proteins are secreted either through the conventional ER-Golgi apparatus pathway, or
through unconventional pathways (Rabouille et al., 2012). The majority of proteins secreted from
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MSU- and ATP-stimulated cells were secreted unconventionally. A more detailed analysis of
secreted proteins revealed that MSU exposure activated vesicle-mediated unconventional protein
secretion including exosomes. Furthermore, ATP stimulation rapidly increased the extracellular
vesicle content of the media compared to the media of unstimulated cells. In line with the data
presented here, vesicle-mediated unconventional protein secretion from macrophages has been
described also from macrophages stimulated with herpes simplex virus 1 (Miettinen et al., 2012)
and 1,3-β-glucans (Cypryk et al., 2014; Öhman et al., 2014). Interestingly, Meissner and co-workers
reported that two thirds of proteins secreted from LPS-stimulated macrophages possessed a signal
peptide or a transmembrane region (Meissner et al., 2013) indicative of the activation of
conventional protein secretion. The reason for differential activation of secretory machinery in
macrophages upon various stimuli is not known. LPS is a potent activator of gene transcription in
the cells (Nau et al., 2002), and the proteins secreted from LPS-activated macrophages were
mainly products of this transcription including cytokines and chemokines (Meissner et al., 2013). It
can be speculated that activation of transcription leads to activation of conventional protein
secretion after longer exposure times.
Cathepsins are lysosomal proteases important for degradation of lysosomal contents (Turk et
al., 2012). There was secretion of active cathepsins B and D from macrophages stimulated with
MSU, implying that the structure of the lysosomes had been compromised, or that secretory
lysosomes had been exocytosed from the cells. Even though cathepsins function optimally in the
acidic environment of lysosomes, they might still retain activity at neutral pH  (Turk et al., 2012).
Secreted cathepsins areable to degrade the extracellular matrix, thus contributing to various
pathologies such as rheumatoid arthritis and neurological disorders (Turk et al., 2012). MSU
crystals evoke potent inflammation in the joints of patients with gouty arthritis (Perez-Ruiz et al.,
2015). It is possible that extracellular cathepsins are involved in MSU-induced inflammation. It
was also observed that blocking of cathepsin B activity inhibited MSU-induced unconventional
protein secretion from the cells, including the secretion of two biologically active cytokines, IL-1β
and IL-18. In contrast, inhibition of cathepsin B activity did not have any effect on MSU-induced
secretion of chemokines, which are secreted through the conventional pathway. Previously,
cathepsin B has been shown to promote autophagy-driven unconventional protein secretion
(Dupont et al., 2011). Autophagy is a process where the cell’s own structures are degraded and
recycled. The material needing to be degraded such as defective organelles is enclosed in
autophagosomes, which fuse with lysosomes providing the enzymes necessary for degradation of
cargo (Rubinsztein et al., 2012). Activation of autophagy has been linked with unconventional
protein secretion including IL-1β, and blockade of autophagy inhibits unconventional protein
secretion (Dupont et al., 2011; Öhman et al., 2014). Activation of autophagy in MSU-stimulated
macrophages was not explored here, but it might have a role in MSU-induced unconventional
protein secretion, and the effect could be mediated by cathepsin B.
There are indications that MSU binds directly to lipid rafts on the cell membrane of the
dendritic cells, which leads to activation of Syk kinase and the phagocytosis of the crystals inside
the cell (Ng et al., 2008). The present study demonstrated that Src kinase activity was required for
overall protein secretion by MSU, including secretion of IL-1β. In addition, it was also
demonstrated that activity of Pyk2 and PI3 kinases was required for MSU-induced protein
secretion from the cells. Syk kinase is typically activated downstream of Src kinases (Bradshaw,
2010). Furthermore, Src, Pyk2 and PI3 kinases operate together in the process of phagocytosis
(Owen et al., 2007; Freeman and Grinstein, 2014). It is likely that Src, Pyk2 and PI3 kinases are
required for phagocytosis of MSU in macrophages, since their blockade inhibited all MSU-induced
secretion from the cells, including that of the activated cathepsins B and D, indicating that they
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function upstream of cathepsins. To support their role in MSU-induced responses, it has previously
been shown that MSU-induced degranulation, a type of secretory response, from the neutrophils is
mediated through Src and PI3 kinases (Popa-Nita et al., 2007). In addition, PI3K has been shown
to mediate MSU-induced IL-1β secretion from mouse macrophages (Cunningham et al., 2012). In
summary, MSU-induced protein secretion from the macrophages is mediated through kinases of
Src family, Pyk2 and PI3K.
Calpains are calcium-activated cytosolic cysteine proteases. Their typical substrates are
cytoskeleton proteins and integrins (Goll et al., 2003). Pathways related to calpain activity were
found to be enriched in the secretome of ATP-stimulated cells. It was demonstrated that after
exposure of extracellular ATP, the activity of calpains increased in a P2X7-dependent manner in
macrophages.  In  line  with the present  data,  it  has  been reported before  that  in  murine dendritic
cells and rat hepatocytes, the activity of calpains in the cells increases after ATP exposure (Rosser
et al., 1993; Groß et al., 2012). Activation of P2X7 receptor has been shown previously to regulate
the vesicle-mediated unconventional protein secretion. Shedding of microvesicles on P2X7
activation has been detected from monocytic THP-1 cells, astrocytes and dendritic cells (MacKenzie
et al., 2001; Bianco et al., 2005; Pizzirani et al., 2007). Furthermore, P2X7 receptor activation has
also been linked to the exocytosis of secretory lysosomes from murine macrophages (Qu et al.,
2007; Bergsbaken et al., 2011), and the secretion of exosomes from murine macrophages and
dendritic cells (Qu et al., 2007; Qu et al., 2009). Here it was demonstrated that ATP-induced
vesicle secretion was completely dependent on the activity of calpains. In platelets, calpains have
been linked with secretory events when the cells were activated with thrombin (Croce et al., 1999).
However, it does seem that the present results are the first evidence that calpains regulate P2X7-
mediated extracellular vesicle release from human immune cells.
It  was  found  that  the  activity  of  calpains  was  required  for  secretion  of  IL-1β upon  ATP
exposure. The secretion of IL-1β on ATP stimulation is known to be dependent on the activation of
the NLRP3 inflammasome (Mariathasan et al., 2006). It was observed that if one inhibited calpain
activity, then the NLRP3 inflammasome was not normally assembled, as the usual oligomerization
of ASC was prevented. It was also demonstrated that blockade of calpain activity completely
inhibited ATP-induced K+ efflux from the cells, which is required for inflammasome activation
(Muñoz-Planillo et al., 2013). These data indicate that the activity of the calpains is required for
NLRP3 inflammasome activation in ATP-exposed macrophages. Interestingly, in a recent report it
was shown that various inflammasome activators including ATP induce cell necrosis by eventual
loss of membrane integrity due to K+ efflux, and the release of mature IL-1β occurs exclusively from
these necrotic cells (Cullen et al., 2015). This further supports our finding that calpain activity is
required  for  ATP-induced  secretion  of  IL-1β,  since  by  using  calpain  inhibitor  K+ efflux  from  the
cells was clearly blocked. In the current study it was also noted that calpains were needed for the
secretion of IL-1β from the 1,3-β-glucan-stimulated macrophages, but not from nigericin-
stimulated macrophages. Nigericin is a potassium ionophore which is able to induce K+ efflux from
the cells, and it does not require the P2X7 receptor to activate macrophages (Perregaux and Gabel,
1994; Le Feuvre et al., 2002). This might explain why blockade of calpain activity did not exert any
effect on IL-1β secretion by nigericin. On the other hand, 1,3-β-glucans are mainly detected by the
dectin-1 receptors on macrophages (Brown and Gordon, 2001; Brown et al.,  2002). However, the
addition of apyrase, an enzyme degrading extracellular ATP, into the cell culture media of human
macrophages treated with 1,3-β-glucans clearly inhibited the secretion of IL-1β from the cells
(unpublished observation). This indicates that macrophage responses after exposure to 1,3-β-
glucans are at least partially dependent on the release of ATP into the extracellular environment.
This might explain the similar results obtained from ATP and 1,3-β-glucans on the necessity of
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calpains on IL-1β secretion from the cells. However, more experiments will be needed to verify this
hypothesis.
The P2X7 receptor forms a receptor complex consisting of multiple proteins on the cell
surface. Studies conducted with THP-1 cells, and P2X7-transfected HEK293-cells and cervical
endothelial cells have shown that P2X7 complexes with multiple cytoskeleton proteins including
integrin  β2,  and  heat-shock  proteins  (Kim  et  al.,  2001;  Gu  et  al.,  2009).  Here,  by  blocking  the
activity of calpains, it was demonstrated that there was inhibition of the downstream effects of
P2X7 activation on membrane trafficking and protein secretion, as well as prevention of NLRP3
inflammasome activation. This suggests that ATP-induced signaling from P2X7 receptor was
blocked at the proximal end of the signaling cascade. It is tempting to speculate that calpain
cleavage of a P2X7 receptor complex protein is required for the signal to proceed from the receptor.
Strong candidates would be integrin β2 or β-actin, as they have been detected in P2X7 receptor
complexes (Kim et al., 2001), and are known calpain substrates according to CaMPDB, a calpain
substrate database (duVerle et al., 2009). However, future studies will be required to verify this
hypothesis. In summary, ATP induces a calpain-dependent rapid secretion of extracellular vesicles
from the macrophages. Furthermore, the activity of calpains is required for ATP-induced activation
of NLRP3 inflammasome in cells.
Activated caspase-1 has been postulated to regulate unconventional secretion of proteins,
also for proteins that are not caspase-1 substrates (Keller et al., 2008). This would make
inflammasome an even more crucial regulator of the innate immune responses. It was shown here
that agonists able to activate NLRP3 inflammasome induced also unconventional protein secretion
from  the  macrophages.  This  was  revealed  for  MSU  and  ATP  in  this  thesis,  but  it  has  been  also
shown for influenza A and 1,3-β-glucan (Lietzén et al., 2011; Öhman et al., 2014). It was also
observed that blockade of calpain activity inhibited both inflammasome activation and
unconventional protein secretion after ATP exposure in macrophages, suggesting that protein
secretion might be regulated by inflammasome activation. However, no evidence was found that
the activity of caspase-1 would be required for ATP-induced overall unconventional protein
secretion from macrophages. In line with this data, Groβ and co-workers have demonstrated that
protease activity of caspase-1 is dispensable for the secretion of unconventionally secreted IL-1α
upon various stimuli (Groß et al., 2012). Furthermore, Miettinen and co-workers reported that
unconventional protein secretion was activated in macrophages infected with herpes simplex virus-
1 (HSV-1), even though HSV-1 inhibited the activation of the NLRP3 inflammasome in the cells
(Miettinen et al., 2012). These findings suggest that caspase-1 activation is not a universal regulator
of unconventional protein secretion. However, Groβ and co-workers also claimed that the presence
of caspase-1 was required to trigger the secretion of IL-1α since the release was blocked in murine
macrophages deficient in caspase-1 (Groß et al., 2012). This emphasizes that more work will be
required to clarify the role of caspase-1 in protein secretion.
5.2 INFLAMMASOME ACTIVATION IN HUMAN MACROPHAGES
The present study explored the signaling pathways leading to inflammatory response
triggered by trichothecene mycotoxin roridin A in human macrophages. Trichothecene mycotoxins
are the main group of Fusarium mycotoxins; these are a harmful group of fungal toxins affecting
animal and human health, and causing enormous economic damage. Trichothecene mycotoxins are
structurally related toxins produced by non-related species of fungi like Fusarium, Myrothecium
and Stachybotrys (Escrivá et al., 2015). The most common route to exposure of trichothecene
mycotoxins is via contaminated food. Additionally, inhalation of trichothecene mycotoxins might
occur in water-damaged buildings, frequently associated with the Stachybotrys species, S.
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chartarum. There has been claims that there is an association between S. chartarum, its
metabolites and damp-building-associated illnesses (Pestka et al., 2008).
The P2X7 receptor is an ion channel, which is activated by extracellular ATP (Solle et al.,
2001). It was found that roridin A engages the purinergic P2X7 receptor in human macrophages.
The activation of NLRP3 inflammasome is one of the downstream effects of P2X7 activation,
leading to activation of caspase-1, and proteolytic processing and secretion of IL-1β and IL-18
(Mariathasan et al., 2006). It has been shown previously that three trichothecene mycotoxins,
roridin A, verrucarin A and T-2 toxin, could activate inflammatory reactions from human
macrophages, as they were found to cause caspase-1 –mediated IL-1β and IL-18 secretion from the
cells (Kankkunen et al., 2009). Here it was found that roridin A activates IL-1β and IL-18 secretion
from LPS-primed macrophages and that is dependent on the NLRP3 inflammasome, providing a
mechanistical explanation for the previous finding that trichothecene mycotoxins activate caspase-
1. It was not explored how roridin A interacts with the P2X7 receptor. It might directly bind to the
receptor, similar to the receptor’s endogenous ligand ATP or alternatively, it might have an indirect
effect. Trichothecene mycotoxins are small molecules that can move passively through cell
membranes (Escrivá et al., 2015). In a previous study, it was shown that trichothecene mycotoxins
could trigger apoptosis in macrophages (Kankkunen et al., 2009). Furthermore, it has been shown
that during apoptosis, the cell membrane channel pannexin-1 dilates and releases ATP into the
extracellular environment to provide a “find me” signal for phagocytes, such as macrophages (Qu et
al., 2011). Thus it is possible that roridin A triggers apoptosis in macrophages, which release ATP
that is detected by P2X7 receptors on other macrophages activating the NLRP3 inflammasome and
cytokine secretion.
This study revealed that roridin A -induced NLRP3 inflammasome activation was dependent
on activity of cathepsins. The requirement of cathepsin activity on NLRP3 inflammasome
activation is a widely recognized phenomenon. Hornung and co-workers demonstrated that
particulate matter silica and aluminium salts could interact with the NLRP3 inflammasome by
activating phagocytosis in the macrophages. Phagocytosis leads to damage and rupture of
lysosomes, and the leakage of lysosomal contents into the cytosol and this activates the NLRP3
inflammasome (Hornung et al., 2008). Cytoplasmic activity of lysosomal protease cathepsin B was
associated with NLRP3 activation (Hornung et al., 2008). In addition to silica and aluminium salts,
amyloid-β (Halle et al., 2008), cholesterol crystals (Duewell et al., 2010; Rajamäki et al., 2010), 1,3-
β-glucans (Kankkunen et al., 2010), influenza A (Lietzén et al., 2011), long needle-like carbon
nanotubes  (Palomäki  et  al.,  2011),  and serum amyloid A (Niemi et  al.,  2011)  have been shown to
activate the NLRP3 inflammasome in a cathepsin dependent manner. Importantly, P2X7 activation
has been shown to lead to lysosomal destabilization, and leakage of active cathepsins into cytosol
(Lopez-Castejon et al., 2010; Hoegen et al., 2011) providing a possible mechanism to explain how
trichothecene mycotoxins could engage cathepsins. However, the detailed mechanisms to
determine how cathepsin activity is required for inflammasome activation remains to be unraveled.
The experiments conducted with mice defective in cathepsin B have not been conclusive about its
role  as  activator  of  NLRP3  inflammasome  (Dostert  et  al.,  2009),  and  it  is  possible  that  there  is
redundancy between the functions of the individual cathepsins, the signaling pathways leading to
inflammasome activation are different in mice and humans, or that there are alternative pathways
utilized in addition to the cathepsins (Tschopp, 2011).
The  formation  of  ROS  has  been  suggested  to  be  the  common  trigger  that  is  required  in
NLRP3  inflammasome  assembly  (Tschopp  and  Schroder,  2010).  Here,  it  was  observed  that
blockade of reactive oxygen species (ROS) inhibited IL-1β and IL-18 secretion from LPS-primed
macrophages treated with roridin A. It has been shown before that certain NLRP3 agonists i.e.
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ATP, MSU and asbestos, could induce the formation of ROS in macrophages and THP-1 cells, and
that blockade of ROS inhibited the secretion of mature IL-1β from the cells treated accordingly
(Cruz et al., 2007; Dostert et al., 2008). P2X7 activation has been shown to stimulate ROS
production  in  macrophages  (Lenertz  et  al.,  2009),  and  therefore  P2X7  signaling  might  be  the
pathway through which ROS are generated after roridin A exposure.
The involvement of ROS in NLRP3 inflammasome activation has been controversial.
Bauernfeind and co-workers proposed that ROS were not needed for the activation of the NLRP3
inflammasome  complex,  but  were  necessary  for  the  priming  step  and  production  of  NLRP3
protein, which they had previously shown to be a limiting factor for inflammasome activation in
murine macrophages (Bauernfeind et al., 2009; Bauernfeind et al., 2011b). The present study
demonstrated that the priming step was not affected in human macrophages by ROS inhibitors
after roridin A exposure. Recently, Muñoz-Planillo and co-workers showed using murine
macrophages  that  ROS  production  was  not  needed  in  either  the  priming  or  the  activation  of  the
inflammasome (Muñoz-Planillo et al., 2013). However, the blocking effect from human
macrophages observed here was obtained with much lower concentrations of ROS inhibitors than
used by these other workers. The controversies of these results likely reflect the differences in the
cell models being used. To highlight the differences in human and murine macrophages, it was
found here that NLRP3 inflammasome activation occurred also in non-primed human
macrophages, as roridin A alone activated IL-18 secretion from the cells. Furthermore, it was
demonstrated that ATP stimulation activated the secretion of biologically active caspase-1 from
non-primed human macrophages. Both findings imply that in human primary macrophages,
NLRP3 inflammasome complex becomes activated in response to agonist detection even without
priming, in contrast to data derived from murine macrophages.
To date, all of the known NLRP3 inflammasome activators trigger K+ efflux from the cells.
This has been shown to be an essential and sufficient upstream signaling event to trigger NLRP3
inflammasome activation (Petrilli et al., 2007; Muñoz-Planillo et al., 2013). In line with current
literature, it was also observed in the present study that addition of potassium chloride to the cell
culture media which prevented the K+ efflux also blocked the NLRP3 inflammasome activation
after roridin A exposure. The molecular mechanism explaining how lowering of the K+ content of
the cells triggers NLRP3 inflammasome assembly remains to be determined. It is tempting to
speculate that NLRP3 directly binds K+ ions, which could stabilize the protein in an inactive state.
Subsequently K+ efflux from the cells would dissociate K+ ions from the NLRP3 proteins causing its
destabilization and its aggregation with other NLRP3 proteins, ultimately leading to assembly of
the inflammasome protein complex. However, no experimental evidence has been presented to
support this theory.
Tyrosine kinases are crucial intracellular signaling molecules in innate and adaptive immune
cells. The Src family of kinases are the major kinases operating in innate immune cells immediately
downstream of various receptors, including immunoreceptors, cytokine receptors, integrins and
some PRRs (Lowell, 2011). In the present study, it was found that the activity of Src family kinases
was essential for the regulation of NLRP3 inflammasome activation by trichothecene mycotoxins
roridin  A  and  verrucarin  A.  Furthermore,  as  discussed  above,  P2X7  signaling  was  found  to  be
essential for roridin A-stimulated NLRP3 inflammasome activation. It has been shown previously
that Src kinase is able to bind directly to the P2X7 receptor, and it is involved in signal transduction
events from the receptor (Iglesias et al., 2008). This might explain the observation that inhibition
of  Src  kinase  prevented  NLRP3  inflammasome  activation  in  response  to  exposure  to  a
trichothecene mycotoxin. Here it was also noted that Src family kinases were required for
activation of the AIM2 inflammasome, a detector of cytosolic double-stranded DNA.
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Activity of Src kinases has been shown to be important in inflammasome activation also
previously. Lyn kinase, a member of the Src family, was found to be essential in inflammasome
activation by malarial hemozoin, which is a particulate agonist of the NLRP3 inflammasome (Shio
et al., 2009). It has been also demonstrated that the activity of Src family kinases was needed for
the secretion of IL-18 and IL-1β in conditions of viral infection (Lietzén et al., 2011). Src kinases are
commonly associated with the signaling directly downstream of receptors, and Syk kinases are
activated downstream of the Src kinases (Bradshaw, 2010). Interestingly, recently Hara and co-
workers demonstrated that Syk- and Jnk-kinase-dependent signaling led to phosphorylation of
ASC that was critical for NLRP3 and AIM2 inflammasome assembly and caspase-1 activation (Hara
et  al.,  2013).  Furthermore,  Lin  and  co-workers  showed  that  Syk  directly  phosphorylated  ASC
promoting NLRP3 inflammasome activation, but negatively regulated gene expression of NLRP3
and pro-IL-1β (Lin et al., 2015). All of the data presented above highlights the fact that Src and Syk
kinases are important regulators of innate immune responses and inflammasome activity, and that
their roles in innate immune cell signaling cascades will need to be explored further.
5.3 ACTIVATION OF INNATE IMMUNE DEFENSES BY MACROPHAGES
Macrophages become rapidly activated upon detection of microbe-derived or endogenous
danger signals. They start to secrete proteins affecting the responses of other immune cells to the
insult. The present study characterized the proteins secreted from human macrophages after the
concerted detection of the microbe-derived LPS and the endogenous danger signal, MSU.
Strikingly, many groups of inflammation-inducing proteins including interferon-induced proteins,
and cytokines and chemokines were discovered to be secreted from the cells. It was found that LPS-
priming was responsible for their production inside the cell. However, MSU triggered the efficient
secretion of interferon-induced proteins and chemokines from the cells. Cytokines and chemokines
have apparent functions outside the cell, and extracellular properties of many interferon-induced
proteins like IFIT-1 are emerging (Pichlmair et al., 2011). Likewise, danger signal proteins like
heat-shock proteins (HSPs), S100-proteins, and galectins were found to be secreted from LPS-
primed MSU-stimulated cells.
All the detected danger signal protein families are specifically secreted from the activated
cells by the unconventional pathway, and they have a role in inflammation (Bianchi, 2007). HSPs
have been observed to form complexes with antigenic peptides in the extracellular environment
and to promote their uptake and cross-presentation by antigen presenting cells (Schmitt et al.,
2007). HSPs also induce cytokine production from innate immune cells through binding of various
receptors including TLRs, although the presence of LPS bound to HSPs might have influenced the
responses (Schmitt et al., 2007). S100 proteins are found in inflamed tissues where they promote
inflammatory responses like induce cytokine secretion and upregulate adhesion molecules on
phagocytes. Some of them are also known to possess antibacterial and anti-parasitic properties
(Foell et al., 2007). Extracellular galectins are able to bind to the glycan structures on the surface of
pathogens facilitating their recognition by the innate immune cells, thus serving as soluble PRRs
(Vasta et al., 2012). Notably, one danger signal protein, HMGB1, which is released passively from
necrotic cells (Scaffidi et al., 2002) was not detected to be secreted from MSU-stimulated cells.
This indicates that MSU-stimulated cells were actively secreting inflammation-promoting proteins
from the cells that had been exposed to LPS. The data presented above demonstrate that detection
of a pathogen-derived signal (LPS) and an endogenous danger signal (MSU) synergistically
promotes a strong inflammatory burst from macrophages.
The effects of the endogenous danger signal, i.e. extracellular ATP, on protein secretion were
also characterized from macrophages that were not primed with LPS. Remarkably, it was not
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possible to detect any cytokines or chemokines being secreted from the cells, nor any interferon-
induced proteins. It might be speculated that most probably if the cells had been primed with LPS
then it would have been possible to demonstrate that these inflammation-inducing proteins were
also being released from the ATP-stimulated macrophages. In fact, Groessl and co-workers co-
stimulated THP-1 cells with LPS and ATP, and they identified a range of cytokines being secreted
from the cells (Groessl et al., 2012). In contrast, here it was noted that danger signal proteins
including HSPs, S100-proteins and galectins were being released from ATP-stimulated
macrophages. This highlights the concept that proteins related to defense reactions against
pathogens i.e. cytokines, chemokines and interferon-induced proteins, are not being constantly
produced in macrophages, and in this way they differ from the danger signal proteins that are
common intracellular proteins which possess biochemical functions during normal homeostasis
(Bianchi, 2007). It is noteworthy that some danger signal proteins stimulate TLRs (Piccinini and
Midwood, 2010), and their secretion might lead to changes in the expression of the inflammation
related genes in adjacent cells, thus amplifying the innate immune response if the endogenous
danger signal is not rapidly removed.
It was also found that growth factor M-CSF promoting macrophage polarization towards
anti-inflammatory phenotype was secreted from ATP-induced cells. The macrophages used in the
study were differentiated with GM-CSF, which is known to promote the production of M-CSF
(Lacey et al., 2012). These data indicate that detection of an endogenous danger signal induces the
secretion of M-CSF from the cells. This might promote the macrophage responses leading to tissue
repair. In tissues, both GM-CSF and M-CSF are likely to be present and their relative levels will
affect  the  phenotype  of  the  macrophages  (Higgins  et  al.,  2008).  Future  studies  will
hopefullyprovide better insights into the phenotypic differences and responses of tissue
macrophages.
Reactive arthritis (ReA) is a sterile joint inflammation developing after an infection of
gastrointestinal or urogenital tract by bacteria like Yersinia enterocolitica (Baeten et al., 2002).
Even  though  ReA  and  other  spondyloarthropathies  (SpA)  have  been  studied  for  decades,  the
complex pathogenesis leading to these disorders is yet to be unraveled. There is now evidence to
suggest that it is altered responses of innate immune cells including macrophages that drives the
inflammation present in SpA (Ambarus et al., 2012). Recently, the role of IL-1β in the pathogenesis
of multiple inflammatory disorders has emerged but its involvement in SpA is still uncertain
(Dinarello and van der Meer, 2013; Hreggvidsdottir et al., 2014). The present study investigated
the activation of the inflammasome in peripheral blood mononuclear cells (PBMCs) and
macrophages differentiated from the monocyte fraction of PBMCs of healthy subjects who had
previously suffered from ReA. It was demonstrated that the secretion of IL-1β was similar than that
from cells of healthy control subjects suggesting that inflammasome activation is normal in
subjects who had recovered from ReA.
These results were validated by measuring the inflammasome activation in patients with
Muckle-Wells syndrome (MWS) and Familial Cold auto-inflammatory syndrome (FCAS). MWS
and FCAS are caused by mutations in the NLRP3 gene leading to an amino acid substitution in the
protein product (Hoffman et al., 2001). In these subjects, the regulation of the assembly of the
NLRP3 inflammasome is disturbed due to the presence of the mutated NLRP3 protein leading to
an abnormally high secretion of IL-1β, and subsequent periodic systemic inflammatory flares
(Agostini et al., 2004; Lachmann et al., 2009). It was noted that especially macrophages of MWS
and FCAS patients showed consistently higher IL-1β secretion after exposure to all of the tested
stimuli than from macrophages obtained from the other studied groups. Inflammasome activation
is regulated differently in monocytes and macrophages. In monocytes, one signal, typically
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mediated through TLRs, is sufficient to activate the inflammasome and to achieve the release of
processed IL-1β from the cells (Piccini et al., 2008; Netea et al., 2009). In contrast, macrophages
require a second signal, commonly mediated through NLRs, to efficiently activate the
inflammasome (Netea et al., 2009). In addition, macrophages have to be differentiated for many
days prior to the experiments and during this time, the cells undertake changes in their production
of inflammatory mediators including down-regulation of constitutive transcription of pro-IL-1β
(Pirhonen et al., 1999). These differences in macrophages compared to monocytes favor
macrophages as a model for study of activation of inflammasome.
The production of IL-12, IL-6, TNF and IL-23 was also studied from the macrophages which
were exposed to various pathogen-derived stimuli, and an increased trend was found for the
secretion of IL-23 and TNF from HLA-B27 positive ReA cells to HLA-B27 positive control cells to
HLA-B27 negative control cells. HLA-B27 is strongly associated with SpA, but the mechanism to
explain how it affects the pathogenesis is not known (Ambarus et al., 2012). It has been suggested
that the pathogen-derived peptides it presents are arthritogenic, leading to molecular mimicry and
damage of host tissues by CD8+ T cells (Hermann et al.,  1993). Furthermore, HLA-B27 has been
proposed to form dimers on the cell surface, and to misfold in ER and these changes can alter the
immune responses from the cells (Allen et al., 1999; Colbert et al., 2014). In line with the present
data, Braun and co-workers have shown that PBMCs from HLA-B27 positive ReA patients secrete
less TNF than cells of HLA-B27 negative ReA patients (Braun et al., 1999). In their study, the low
TNF secretion was associated with a  longer  duration of  ReA.  The role  of  TNF in pathogenesis  of
ReA has not been fully determined. It is known that blockade of TNF can relieve the inflammation
in SpA patients, but there are indications that other major pathways are involved in the
pathogenesis of the disease (Hreggvidsdottir et al., 2014). Here,reduced secretion of TNF from
macrophages of subjects with a history of ReA was observed, but in other studies higher or similar
TNF secretion from PBMCs or monocytes of subjects with a history of ReA compared to healthy
controls  have  been  observed  (Repo  et  al.,  1988;  Repo  et  al.,  1991;  Anttonen  et  al.,  2006).  These
conflicting results may be attributable to the utilization of different cells models and/or stimulants.
The observed effect of less efficiently secreted cytokines seems to be specific for the Th17
pathway, since IL-23 together with IL-6 is known to promote the maturation and maintenance of
Th17 T cells in an environment containing also TGF-β or IL-1β (Ghoreschi et al., 2010; Zhu et al.,
2010). In the present study, secretion of IL-12, a cytokine controlling the maturation of Th1
pathway, was similar between the groups. There are several lines of evidence that IL-23 and Th17
responses are strongly linked to the pathogenesis of SpA (Hreggvidsdottir et al., 2014). In genome-
wide studies, the IL-23 receptor IL-23R has been identified as a susceptibility gene for ankylosing
spondylitis  (Reveille,  2012).  Moreover,  genes  encoding  for  IL-12B  (p40),  a  part  of  the  IL-23
cytokine, and STAT3, a signaling molecule activated downstream of IL-23R and critical for Th17
differentiation, have been associated with ankylosing spondylitis. Furthermore, increased secretion
of IL-23 was observed from PBMCs and macrophages of subjects with ankylosing spondylitis
compared to cells from healthy controls (Wang et al., 2009; Zeng et al., 2011), or from dendritic
cells of patients with ankylosing spondylitis compared to cells from patients with rheumatoid
arthritis (Prevosto et al., 2012). However, it should be noted that ankylosing spondylitis is a chronic
inflammatory disorder, whereas subjects with ReA recover usually completely. There is much less
data available on Th17 cytokine secretion from the cells of subjects with ReA. Higher levels of
synovial fluid concentrations of IL-17, IL-6, TGF-β and IFN-γ have been measured from subjects
with ReA compared to subjects with rheumatoid arthritis, evidence of an active Th17 response in
ReA (Singh et al., 2007). However, the measurements in that work were conducted in the synovial
fluids of subjects with active disease, whereas the cells in the present study were from healthy
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subjects with a history of ReA. It would be informative to compare the responses of macrophages
during the active phase of ReA to the present data.
There are indications that the elimination of bacteria causing the infection is inefficient in
ReA  (Rihl  et  al.,  2006).  For  instance  persistent  infection  of Yersinia in ReA has been described
(Hill Gaston et al., 1999). The reduction in the secretion of the pro-inflammatory cytokines
discovered here might contribute to the impaired elimination of bacteria, which could have a role
in pathogenesis of ReA.
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6. CONCLUSIONS AND FUTURE PERSPECTIVES
The innate immune response is a vital part of immunity contributing to direct elimination of
pathogens, and repairing of tissue damage. It also provides the necessary signals to adaptive
immune system to activate antigen-specific defense responses. The crucial functions of the innate
immune system for host defense in higher vertebrates has only been recognized for a relatively
short time, and the whole spectrum of secretory responses from central effector cells macrophages
and dendritic cells to the wide array of activators is not completely known. This thesis concentrated
on the early secretory events occurring in macrophages activated by microbe-derived and
endogenous danger signals. The signaling cascades leading to assembly of inflammasome, a
molecular complex regulating the secretion of pro-inflammatory cytokines and initiation of
inflammatory response in activated macrophages, were also studied.
Macrophages receive signals through a variety of receptors, and activation of different
signaling cascades triggers different effects to allow the cells to respond appropriately to these
diverse environmental cues. It was discovered that co-stimulation of macrophages with the
microbe-derived signal, LPS, and the endogenous danger signal, MSU, achieved a robust vesicle-
mediated protein secretion from the macrophages. The proteins released included cytokines and
chemokines, interferon-induced proteins and danger signal proteins. It was also shown that
detection of LPS activated the transcription of cytokines, chemokines and interferon-induced
proteins, but MSU initiated their efficient secretion from the cells. Upon detection of pathogens
simultaneously with tissue damage, the response has to be strong enough to limit the further
destruction of tissues. It was also shown that detection of another endogenous danger signal,
extracellular ATP, could evoke a rapid release of extracellular vesicles from macrophages and the
secreted proteins included danger signal proteins. These data highlight that the detection of
endogenous danger signals with or without the presence of a microbe-derived signal, results in
different responses from macrophages. The responses of the macrophages are fine-tuned not only
by the strength but also by the types of combination of various signals present in the environment.
Clearly, a holistic approach including studying the effects of multiple simultaneous environmental
factors is needed to understand the full spectrum of responses derived from macrophages.
The regulation of protein secretion from macrophages upon MSU and ATP exposure was also
studied. The MSU-induced unconventional protein secretion from macrophages was shown to be
dependent on the activity of a lysosomal protease, cathepsin B. Src, Pyk2 and PI3 kinases were also
demonstrated to mediate the secretory response from the MSU-stimulated cells. It was discovered
that a group of cytosolic Ca2+-activated proteases i.e. calpains, regulate ATP-induced vesicle-
mediated protein secretion. The activity of calpains was also required for ATP-induced activation of
NLRP3 inflammasome, and secretion of IL-1β. The data presented here highlight that secretome
characterization by biological MS represents a useful tool for unravelling the plethora of
macrophage-derived signals emitted after detection of activators of the innate immune cells. It also
provides new information about signaling cascades activated inside the cells.
The signaling cascade triggered by the fungal produced trichothecene mycotoxin, roridin A,
in human macrophages was also studied. Trichothecene mycotoxins are thought to contribute to
adverse health effects associated with water-damaged buildings. It was shown that roridin A
activates NLRP3 inflammasome, leading to the secretion of the inflammatory cytokines IL-1β and
IL-18 from the cells. Trichothecene mycotoxins are thus regarded as exogenous danger signals to
innate immunity. These results demonstrate that trichothecene mycotoxins present in damaged
materials or in the ambient air of water-damaged buildings might contribute to adverse health
effects experienced by individuals exposed to these toxins. Roridin A-induced NLRP3
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inflammasome activation was mediated through stimulation of the P2X7 receptor, production of
reactive oxygen species, activity of cathepsin B, efflux of potassium from the cells, and the activity
of family of Src kinases. These data can be utilized in understanding and potentially in improving
the treatment of fungi-associated inflammatory disorders.
Reactive arthritis is a sterile joint inflammation associated with bacterial infection in another
compartment of the host. In the present study, it was demonstrated that inflammasome activation
was normal in macrophages of healthy subjects with a history of ReA if these cells were activated by
exposure to microbe-derived signals. However, there was reduced secretion of cytokines IL-23 and
TNF from macrophages of HLA-B27 positive ReA subjects compared to cells of healthy controls.
This suggests that the strength of the early innate immune responses upon detection of pathogens
might have a role in pathogenesis of ReA. These results also could act as a basis for future studies
exploring the global secretion of proteins from cells of subjects with a history of ReA; this study
might well reveal novel insights about macrophage responses.
This study provides new information about early innate immune responses. The innate
immune cells encounter multiple endogenous and exogenous signals in their environment, and it is
the combination of these signals that dictates the ultimate cellular response. Understanding innate
immune responses and how they are regulated can be useful in the discovery of novel treatments
for the kinds of diseases, whose pathogenesis is associated to disturbances in the innate immune
system. Detailed knowledge of innate immune responses can also be used for manipulating these
responses into a desirable direction. For example, this could be advantageous in the development
of novel vaccines, as it is the innate immune responses that guide the adaptive immune responses
towards antigens, leading to protective immunity against diseases.
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